Exchange Agreement



 Exhibit 10.1 
 November 24, 2008 
 Fairholme Funds, Inc. 
 4400 Biscayne Boulevard, 9th Floor 
 Miami, FL 33137 
 Attention: President 
 Dear Mr. Berkowitz: 
 This letter agreement is intended to confirm our agreement regarding the terms of the exchange (the “Exchange”) of (i) our 8.50% Senior Notes due 2015 held by you (the “Notes”)
and the subject of the Indenture, dated as of June 28, 2007, with HSBC Bank USA, National Association, as Trustee, for (ii) an aggregate of 15,122,670 shares of our common stock, par value $.01 per share (the “Common
Stock”), of AmeriCredit Corp., a Texas corporation (the “Company”). 
 We have agreed as follows: 
 1. The Exchange. Subject to the terms hereof, the Company agrees to issue to you an aggregate of 15,122,670 shares of Common Stock (the
“Company Shares”) in exchange for an aggregate principal amount of the Notes held by you (the “Exchange Notes”) on the Closing Date (as herein defined) equal to the Exchange Note Amount (as herein defined), and you
agree to deliver the Exchange Notes to the Company for cancellation on the Closing Date in exchange for the Company Shares. The Company shall deliver the Company Shares in accordance with written instructions received from you at least two
(2) days prior to the Closing Date, together with cash in an aggregate amount equal to the sum of (i) an amount equal to the accrued and unpaid interest on the Exchange Notes until the occurrence of the Closing Date, and (ii) the
Fractional Amount (as herein defined), by wire transfer to an account set forth in written instructions received from you at least two (2) days prior to the Closing Date, and you shall deliver the Exchange Notes to the Company in the manner set
forth in paragraph 2 of this letter agreement. In the case of the exchange of Notes having an aggregate principal amount exceeding the Exchange Note Amount, the Company shall cancel the Notes delivered to the Company hereunder and shall execute and
deliver a new Note to you of like tenor having a principal amount equal to such excess aggregate principal amount over the principal amount of the Exchange Notes to be delivered to the Company hereunder. As used herein, the term “Exchange
Note Amount” shall mean an aggregate face amount of Notes held by you determined by multiplying the lesser of (i) 120% of the average of the closing prices of the Common Stock on the New York Stock Exchange for each of the ten
consecutive days on which such exchange is open for trading immediately preceding the Closing Date, or (ii) $6.02, by 15,122,670, and then dividing the product so obtained by 0.84; provided, if the amount so produced is not evenly divisible by
1,000, the Exchange Note Amount shall be rounded up to an amount that is evenly divisible by 1,000 (the difference between the amount derived after dividing such product by 1,000 and the Exchange Note Amount is referred to herein as the
“Fractional Amount”). 







 2. Closing. In order to complete the Exchange, we will hold a closing on the latest of
(a) the day that the Securitization Transaction (as defined herein) is consummated, (b) the next business day after the expiration of the 10 day period following the mailing by the Company to its shareholders of a letter alerting them to
the issuance of the Company Shares and its omission to seek shareholder approval as required by Rule 312.05 of the NYSE Listed Company Manual, and (c) the next business day after all waiting periods applicable to the Exchange under the
Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act”), have expired or early termination of any waiting periods has been received (such date being referred to as the “Closing Date”). Prior
to the Closing Date, the Company will deliver to one or more custodians for you, one or more certificates registered in the name of the nominee of the custodian, evidencing the Company Shares against delivery of the Exchange Notes to HSBC Bank USA,
National Association, for the benefit of the Company, through the facilities of The Depository Trust Company (“DTC”). The custodians will execute such documents as reasonably necessary to evidence receipt of such certificates. If
for any reason the closing does not occur within twenty-four hours of the Company’s delivery to the custodians of the certificates, the custodians shall immediately return such certificates to the Company or an authorized representative
thereof. At the closing, you will cause to be delivered to HSBC Bank USA, National Association, for the benefit of the Company, the Exchange Notes through the facilities of DTC, and then the Company will cause to be delivered to you the Company
Shares through the facilities of your custodian. 
 3. The Company’s Representations. The Company represents and warrants
to you as follows: 
 (a) Organization, Authority, etc. The Company (i) is a corporation duly incorporated and validly existing
under the laws of the State of Texas, (ii) is not an “investment company” as defined in the Investment Company Act of 1940, as amended, (iii) has all requisite corporate power to own or lease and operate its properties and assets
and to carry on its business as now conducted, and (iv) is duly qualified or licensed to do business and is in good standing as a foreign corporation in all jurisdictions in which it owns or leases property or in which the conduct of its
business requires it so to qualify or be licensed, except in each of case (iii) and (iv) as could not, individually or in the aggregate, reasonably be expected to have a material adverse effect on the assets, business, properties or
financial condition of the Company and its subsidiaries, taken as a whole. The Company has all requisite corporate power to enter into this letter agreement and the other Transaction Documents, to issue the Company Shares and to perform its
obligations hereunder and thereunder. 
 (b) Corporate Acts and Proceedings. The execution and delivery of this letter agreement and
the Transactions contemplated hereby have been duly and validly authorized by the Company, and all necessary corporate action has been taken to make this letter agreement and each other Transaction Document a legal, valid and binding obligation of
the Company, enforceable in accordance with its terms, except that the enforcement thereof may be subject to bankruptcy, insolvency, reorganization, moratorium or other similar laws now or hereafter in effect relating to creditors’ rights
generally and to general principles of equity (regardless of whether such enforcement is considered in a proceeding in equity or at law). The execution and delivery of this letter agreement and each other Transaction Document and the consummation of
the Transactions contemplated hereby and thereby do not require any governmental or other third party consent, registration or approval other than (i) in connection with the HSR Act, (ii) as contemplated by the Registration Rights
Agreement, and (iii) for approval of the Company Shares for listing on the New York Stock Exchange. 
  

 2 








 (c) Valid Issuance. Upon delivery by you of the Exchange Notes to HSBC Bank USA, National
Association, for the benefit of the Company, through the facilities of DTC, the Company Shares when issued will be duly and validly issued, fully paid and nonassessable. 
 (d) Financial Statements and Reports. The Company has timely filed all reports, schedules, forms, statements and other documents required to be filed by it with the Securities and Exchange Commission (the
“SEC”) during the last three years pursuant to the reporting requirements of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The Company’s most recent annual report on Form 10-K and each
other report, registration statement, proxy statement and other document filed with the SEC during the last three years (the “SEC Documents”) complied at the time of filing (or, if amended, at the time of amendment) in all material
respects with the requirements of the Exchange Act, and, as of the date of filing with the SEC, none of the SEC Documents contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or
necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading. 
 (e)
Compliance with Other Instruments. Neither the execution and delivery by the Company of this letter agreement or any of the other Transaction Documents (as defined below), nor the consummation of the transactions contemplated hereby or
thereby will (i) conflict with or result in a breach or violation of any of the terms and provisions of, or constitute a default under, any indenture, mortgage, deed of trust, loan agreement or other material agreement or instrument to which
the Company is a party or by which the Company is bound or to which any material property or assets of the Company are subject, (ii) result in any violation of the provisions of the articles of incorporation or by-laws of the Company,
(iii) result in any violation of any statute or any order, rule or regulation of any court or governmental agency or body having jurisdiction over the Company or any of its respective properties, which is binding on the Company,
(iv) result in the creation under any agreement or instrument of any lien, security interest, encumbrance or other claim upon any of the material property or assets of the Company, or (v) create in any person or entity, with the passage of
time or otherwise, any right to terminate any agreement with the Company or otherwise exercise any rights against the Company or cause any payment or performance obligation of the Company to be accelerated, except in each case (iii) and
(v) as could not, individually or in the aggregate, reasonably be expected to have a material adverse effect on the assets, business, properties or financial condition of the Company, taken as a whole. 
 (f) Texas Business Combination Law. Assuming you have not become the beneficial owner of 20% or more of the Company’s outstanding voting
shares prior to the entering into of this letter agreement, and have not been the beneficial owner of 20% or more of the Company’s outstanding voting shares at any time within the three year period preceding the entering into of this letter
agreement, the Company, pursuant to authority evidenced by resolutions of its Board of Directors duly adopted at a meeting thereof, has taken all requisite corporate and other actions to make inapplicable to each of the transactions contemplated by
or permitted under the Exchange Agreement, the Securitization Transaction, the Standstill Letter, the Berkowitz Standstill Letter and the Registration Rights Agreement (collectively, the “Transactions”), and to exempt the
Transactions fully from, the Texas Business Combination Law (“TBCL”). For purposes hereof, the term “beneficial ownership” shall have such meaning ascribed thereto in the TBCL. 
  

 3 








 (g) After giving effect to the transactions contemplated hereby and to the other Transactions, the
Company will not be insolvent. 
 4. Exchanging Holder Representations. You represent and warrant to the Company as follows:

 (a) Authorization. You have the requisite power and authority to enter into this letter agreement and to perform your obligations
hereunder. The execution and delivery of this letter agreement and the transactions contemplated hereby have been duly and validly authorized by you, and all necessary action has been taken to make this letter agreement your legal, valid and binding
obligation, enforceable in accordance with its terms, except that the enforcement hereof may be subject to bankruptcy, insolvency, reorganization, moratorium or other similar laws now or hereafter in effect relating to creditors’ rights
generally and to general principles of equity (regardless of whether such enforcement is considered in a proceeding in equity or at law). 
 (b) Access to Information. The Company has made available to you all reports, schedules, forms, statements and other documents publicly filed by the Company with the SEC for the last three years through the date hereof pursuant to
the reporting requirements of the Exchange Act, and you have received physical delivery of all such documents, records and information which you have requested, and have had adequate opportunity to ask questions of, and receive answers from, the
Company’s officers, employees, and representatives concerning the Company’s business, operations, financial condition, assets, liabilities, or any other matters relevant in making the Exchange. You acknowledge that (i) the Company may
possess and may hereafter possess certain non-public information which may constitute material information with respect to the Company or the Exchange, (ii) you have declined and do hereby decline to receive such non-public information, and
(iii) the Company is relying on the provisions of this paragraph in connection with the Exchange. 
 (c) Title to the Exchange
Notes. Immediately prior to the closing, you will have title to the Exchange Notes, free and clear of all claims, liens, title defects and objections or equities of any kind and nature whatsoever. 
 (d) Securities Act. You represent that you are an “accredited investor” as that term is defined in Rule 501 promulgated under the
Securities Act of 1933, as amended (the “Securities Act”), and that you are acquiring the Company Shares solely for the purpose of investment and not with a view to, or for resale in connection with, any distribution thereof in
violation of the Securities Act. 
 (e) Brokers and Finders. Neither you nor any of your subsidiaries or affiliates, nor any of their
respective officers, directors, employees or agents has utilized any broker, finder, placement agent or financial advisor or incurred any liability for any fees or commissions in connection with the Exchange. 
 (f) Ownership Interest in the Company. As of the date hereof, without giving effect to the Exchange, you, together with the advisory accounts
through which Fairholme 

  

 4 








 
Capital Management, L.L.C. (or any related or Affiliated (as such term is defined under Rule 405 under the Securities Act of 1933, as amended) person or
persons, including, without limitation, those personal and family accounts of the managing member thereof) beneficially owns (within the meaning of Section 13(d) of the Exchange Act) Common Stock, or any Affiliates or any persons with whom
you have formed a group (within the meaning of Section 13(d)(3) of the Exchange Act) (together, the “Restricted Persons”) beneficially own (as defined in Rule 13d-3 of the Exchange Act) in the aggregate 22,717,321 shares
of the Company’s Common Stock. The Restricted Persons have not become the beneficial owner of 20% or more of the Company’s outstanding voting shares prior to the entering into of this letter agreement, and have not been the beneficial
owner of 20% or more of the Company’s outstanding voting shares at any time within the three year period preceding the entering into of this letter agreement. 
 5. Conditions of Parties’ Obligations. The respective obligations of each party to consummate the Exchange are subject only to (a) in the case of the Company’s obligations to consummate
the Exchange, the closing and funding by you of the Securitization Transaction (as hereinafter defined), (b) the expiration or early termination of all waiting periods applicable to the Exchange under the HSR Act, (c) execution and
delivery of the Transaction Documents by the other parties thereto, (d) each of the representations and warranties of the other party set forth herein being true and correct on the Closing Date with the same effect as if made on the Closing
Date, (e) you shall have received from Hunton & Williams LLP, counsel for the Company, a favorable opinion, dated the Closing Date in substantially the form attached hereto as Exhibit A, (f) you having received from the Company a
certificate dated as of the Closing Date executed by an authorized officer of the Company to the effect that the signer of such certificate has carefully examined this Agreement and that: (i) the representations and warranties of the Company in
this Agreement are true and correct at and as of the Closing Date with the same effect as if made on the Closing Date and (ii) the Company has complied with all the agreements and satisfied all the conditions on its part to be performed or
satisfied at or prior to the Closing Date, and (g) the Company has received from you a certificate dated as of the Closing Date executed by an authorized officer to the effect that the signer of such certificate has carefully examined this
Agreement and that: (i) your representations and warranties in this Agreement are true and correct at and as of the Closing Date with the same effect as if made on the Closing Date and (ii) you have complied with all the agreements and
satisfied all the conditions on your part to be performed or satisfied at or prior to the Closing Date. 
 6. Additional Agreements of
the Parties. 
 (a) Securitization Transaction. Subject to the satisfaction of the conditions set forth in that certain note
purchase agreement, dated of even date herewith (the “Note Purchase Agreement”), by and among the Company, AFS SenSub Corp., and Fairholme Funds, Inc., you irrevocably and unconditionally agree to purchase $125 million of the AA/A
rated bonds in the next securitization sponsored by the Company or one of its affiliates (the “Securitization Transaction”), with such AA/A rated bonds having a combined discount and coupon equal to a yield of 18%. You shall
purchase such bonds for cash on the same day that the Securitization Transaction closes. 
 (b) Standstill Letters. Simultaneously
with the issuance of the Company Shares, you and the Company agree to enter into a standstill letter, substantially in the form attached hereto as Exhibit B-1 (the “Standstill Letter”) and you agree to cause Bruce Berkowitz to enter
into a standstill letter, substantially in the form attached hereto as Exhibit B-2 (the “Berkowitz Standstill Letter”). 
  

 5 








 (c) Registration Rights Agreement. Simultaneously with the issuance of the Company Shares, you and
the Company agree to enter into a registration rights agreement, substantially in the form attached hereto as Exhibit C. 
 (d) Taking of
Necessary Actions. Each of the parties hereto agrees to promptly take or cause to be taken all action and promptly to do or cause to be done all things necessary, proper or advisable under applicable laws and regulations to consummate and make
effective the Exchange, including, without limitation, any filings or action required pursuant to the HSR Act. Each party shall execute and deliver both before and after the closing such further certificates, agreements and other documents and take
such other actions as the other party may reasonably request to consummate or implement the Exchange or to evidence such events or matters. 
 (e) HSR Act. You and the Company shall each file as promptly as practical after the signing of this letter agreement the required notifications and reports forms pursuant to the HSR Act and will use their respective reasonable
commercial efforts to furnish promptly any additional information duly requested pursuant to such Act. 
 (f) Securities Laws;
Legends. You acknowledge and agree that upon issuance the Company Shares will not be registered under the Securities Act or the securities laws of any state and that they may be sold or otherwise disposed of only if registered under the
Securities Act or pursuant to an exemption therefrom. You acknowledge and agree that each certificate for the Company Shares shall bear a legend substantially as set forth below: 
 THE SHARES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”) AND MAY NOT BE
SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF (I) AN EFFECTIVE REGISTRATION STATEMENT FOR THESE SHARES UNDER THE ACT OR (II) PURSUANT TO AN APPLICABLE EXEMPTION FROM SUCH REGISTRATION TOGETHER WITH AN OPINION OF COUNSEL REASONABLY
SATISFACTORY TO THE COMPANY TO THE EFFECT THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE ACT. 
 When issued pursuant hereto, the certificates evidencing
the Company Shares shall also bear any legend required by any applicable state blue sky law. 
 (g) Share Listing. The Company shall
promptly use its reasonable best efforts to cause the Company Shares to be, upon official notice of issuance, listed on the New York Stock Exchange. 
 (h) Preemptive Rights. Following the consummation of the Exchange, the Company shall give you notice (an “Issuance Notice”) of any proposed issuance by the Company of any (i) Common Stock
or other security with voting rights or (ii) securities exercisable or convertible into Common Stock or any other security with voting rights (collectively the items in (i) and (ii) being referred to as “New
Securities”), in each case at least five (5) business days 

  

 6 








 
prior to the proposed issuance date. The Issuance Notice shall specify the price or prices at which such securities are to be issued, the form of
consideration to be received by the Company and the other material terms of the issuance. Provided that such purchase by you would not result in a breach of any of your obligations under the Standstill Letter and the acquisition of the New
Securities is permitted under the terms and conditions of the Standstill Letter, you shall be entitled to purchase up to your Pro Rata Share of the New Securities proposed to be issued, at the price or prices, on the terms and for the same form of
consideration specified in the Issuance Notice (provided, however, that if the consideration to be received for such New Securities is not cash, the Board of Directors of the Company shall determine, in its reasonable judgment, the cash equivalent
of such non-cash consideration and you shall be able to acquire your Pro Rata Share for cash). “Pro Rata Share” means the fraction that results from dividing (1) the number of shares of Common Stock owned by you (immediately
before giving effect to the issuance) by (2) the number of shares of Common Stock owned by all of the Company’s stockholders (immediately before giving effect to the issuance). The Company shall have 90 days from the date of the Issuance
Notice to consummate the proposed issuance of any or all of such New Securities that you have not elected to purchase at the price and upon terms that are not materially less favorable to the Company than those specified in the Issuance Notice,
provided that, if such issuance is subject to regulatory approval, such 90-day period shall be extended until the expiration of five (5) business days after all such approvals have been received, but in no event later than 180 days from the
date of the Issuance Notice. If the Company proposes to issue any such Common Stock or other securities after such 90-day (or 180-day) period, it shall again comply with the procedures set forth in this paragraph 6(h). Notwithstanding the foregoing,
the term “New Securities” shall not include, and you shall not be entitled to purchase Common Stock or any other securities as contemplated by this paragraph 6(h) in connection with (A) issuances of Common Stock or securities
to officers or other employees of the Company in connection with such person’s employment with the Company or to members of the Company’s board of directors under any arrangement provided generally to directors for their service as
directors of the Company, (B) issuances of Common Stock, rights, warrants, options and/or convertible or exchangeable securities in connection with any financing transaction, including, without limitation, senior or subordinated notes,
securitizations or similar transactions, commercial bank or non-bank facilities, commitments or arrangements, bridge financing or back-stop facilities, commitments or arrangements, whole-loan purchase facilities, commitments or arrangements, forward
purchase facilities, commitments or arrangements, or other similar facilities, commitments, arrangements or issuances of non-convertible debt obligations or securities, (C) any issuance that, if as a result of such shares of Common Stock or
securities being issued to you, the Company would be required to seek shareholder approval prior to such issuance or seek an exemption from any applicable rules of the New York Stock Exchange or any other stock exchange on which the Common Stock of
the Company is then listed; provided, however, that the limitation set forth in this clause (C) shall not apply if the Company is seeking shareholder approval prior to such issuance or seeking an exemption from any applicable rules of the New
York Stock Exchange or any other stock exchange on which the Common Stock of the Company is then listed in connection with such issuance other than as a result of such shares of Common Stock or securities that would be issued to you, (D) the
conversion or exchange of any of the Company’s preferred stock, warrants, options or other convertible or exchangeable securities, provided, such preferred stock, warrants, options or other convertible or exchangeable securities are outstanding
as of the date of this letter agreement or were issued in connection with a transaction set out in this paragraph 6(h), (E) a merger or consolidation of the Company with another corporation, partnership, limited liability company or business
organization, or the 

  

 7 








 
acquisition of assets from any such entity, (F) any issuance of Common Stock or securities exercisable or convertible for Common Stock in exchange for
the Company’s currently outstanding debt obligations (including any renewals, modifications, extensions, or restatements of currently outstanding debt obligations) (G) a rights offering conducted by the Company on a pro rata basis to the
holders of Common Stock of the Company, or (H) any issuance by the Company of up to an aggregate of 5 million shares of Common Stock or securities exercisable or convertible into up to an aggregate of 5 million shares of Common Stock
(or any combination thereof), in one or more transactions. The rights granted under this paragraph 6(h) shall terminate and be of no further force or effect upon the termination of the restrictions and agreements contained in paragraphs 1 through 6
of the Standstill Letter in accordance with the terms of the Standstill Agreement, and the rights granted under this paragraph 6(h) shall not be exercisable by you if the acquisition of New Securities upon the exercise of the rights granted under
this paragraph 6(h) is otherwise prohibited by the terms of the Standstill Agreement. The rights granted to you under this paragraph 6(h) may not be assigned by you without the prior written consent of the Company. 
 (i) You agree that neither you, nor any of your Affiliates, including all advisory accounts (both now existing or existing subsequent to the date hereof)
through which Fairholme Capital Management, L.L.C. (or any related or affiliated person or persons) beneficially owns at the time in question (within the meaning of Section 13(d) of the Exchange Act) Common Stock and any “group” of
which you or they are a part (collectively, the “Restricted Persons”), will, between the date of this Agreement and the Closing Date, acquire any shares of Common Stock (or rights in respect thereof) such that the Restricted Persons
would become the beneficial owners of 20% or more of the Company’s outstanding voting shares or dispose of any shares of Common Stock (or rights in respect thereof) (other than for dispositions of an aggregate of 492,652 shares of Common Stock,
which dispositions on any given trading day cannot exceed more than five percent (5%) of the average daily trading volume of the Common Stock on the New York Stock Exchange for the previous five (5) trading days on which the Common Stock
is traded on the New York Stock Exchange). The restrictions in this paragraph 6(i) are expressly agreed to preclude you and the other Restricted Persons from engaging in any hedging or other transaction which is or would result in the acquisition or
disposition of shares of Common Stock in contravention of this paragraph 6(i). Such prohibited hedging or other transactions includes, without limitation, any purchase, sale or grant of any right (including, without limitation, any put or call
option) with respect to Common Stock or with respect to any security that includes, relates to, or derives any significant part of its value from such Common Stock. For purposes of determining your compliance with this paragraph 6(i), in determining
ownership, acquisition or disposition of shares of Common Stock, you and the Restricted Persons shall be deemed to own, acquire or to dispose of any shares of Common Stock synthetically owned, acquired or disposed that are subject to a derivative
transaction entered into by you or any other Restricted Person or unwound by you or them, or derivative security acquired by you or any other Restricted Person, which (a) gives you or them the economic equivalent of ownership of an amount of
Common Stock due to the fact that the value of the derivative is explicitly determined by reference to the price or value of the Common Stock, without regard to whether such derivative conveys any voting rights in such Common Stock to you or any
Restricted Person, (b) the derivative is capable of being, or is required to be, settled through delivery of Common Stock, or (c) you or the Restricted Persons have entered into other transactions that hedge the economic effect of such
derivative, and you and the Restricted Persons shall be deemed to have disposed of shares of Common Stock upon the unwinding of any such derivative. For the avoidance of doubt, any change in beneficial ownership resulting 

  

 8 








 
from the termination of investment discretion over shares of Common Stock held in the advisory or managed accounts of Fairholme Capital Management, L.L.C.
shall not be a prohibited disposition of shares of Common Stock (or rights in respect thereof) under this Section. 
 7.
Miscellaneous. 
 (a) Survival of Representations and Warranties. All representations and warranties shall survive the
closing for a period of eighteen (18) months following the closing and all covenants and agreements shall survive the closing until the expiration of any applicable statutes of limitation. 
 (b) Notices. All notices and other communications hereunder shall be in writing and shall be deemed to have been duly given, if delivered
personally, by telecopier or sent by overnight courier as follows: 
  

					
	(i)	 	If to Fairholme Funds, Inc., to:
		
		 	 Fairholme Funds, Inc.
 4400 Biscayne
Boulevard, 9th Floor
 Miami, FL
33137

			
		 	Attention:	 	President
		 		 	Fax: (305) 358-8002
		
		 	With copies to:
		
		 	 Greenberg Traurig, P.A.
 401 E. Las Olas
Blvd., Suite 401
 Fort Lauderdale, Florida 33301

			
		 	Attention:	 	David C. Peck
		 		 	Fax: (954) 765-1477
		
		 	And:
		
		 	 Seward & Kissel LLP
 1200 G
Street, NW, Suite 350
 Washington, DC 20005

			
		 	Attention:	 	Paul Miller
		 		 	Fax: (202) 737-5184
		
	(ii)	 	If to the Company, to:
		
		 	 AmeriCredit Corp.
 801 Cherry
Street
 Suite 3900
 Fort Worth, Texas 76102

			
		 	Attention:	 	Chief Legal Officer
		 		 	Fax: (212) 284-2280

  

 9 









					
		 	With a copy to:
		
		 	 Hunton & Williams LLP
 1445 Ross
Avenue
 Suite 3700
 Dallas, Texas 75202

			
		 	Attention:	 	L. Steven Leshin
		 		 	Fax: (214) 880-0011

 or to such other address or addresses as shall be designated in writing. All notices shall be effective when
received. 
 (c) Entire Agreement; Third Party Beneficiaries; Amendment. This letter agreement, the agreements executed in connection
with the Securitization Transaction, the Note Purchase Agreement, the Standstill Letter, the Berkowitz Standstill Letter, the registration rights agreement and the documents described herein and therein or attached or delivered pursuant hereto or
thereto (collectively, the “Transaction Documents”) set forth the entire agreement between the parties hereto with respect to the Exchange and the transactions contemplated therein, and are not intended to and shall not confer upon
any person other than the parties hereto any rights or remedies hereunder. Any provision of this letter agreement may only be amended or modified in whole or in part at any time by an agreement in writing between the parties hereto executed in the
same manner as this letter agreement. 
 (d) Counterparts. This letter agreement may be executed in two or more counterparts
(including by means of facsimile), each of which shall be deemed to be an original but all of which together shall constitute one and the same instrument. Receipt of an executed signature page to this letter agreement by facsimile or other
electronic transmission shall constitute effective delivery thereof. Electronic records of this executed letter agreement shall be deemed to be originals thereof. 
 (e) Jurisdiction; Governing Law. Each party agrees and consents to personal jurisdiction and service of process and exclusive venue in the federal district court for the Northern District of Texas, Dallas
Division, or the State of Texas for the purposes of any action, suit or proceeding arising out of or relating to this letter agreement. This letter agreement shall be governed by, and construed in accordance with, the laws of the State of Texas,
without regards to its conflicts of law principles. 
 (f) Public Announcements. Subject to each party’s disclosure obligations
imposed by law, each of the parties hereto will cooperate with each other in the development and distribution of all news releases and other public information disclosures with respect to this letter agreement and the Exchange, and no party hereto
will make any such news release or public disclosure without first consulting with the other party hereto. 
  

 10 








 (g) Expenses. Each party hereto shall bear its own costs and expenses incurred in connection with
this letter agreement and the Exchange, provided, however, that the Company shall pay (i) your reasonable, out-of-pocket attorneys’ fees incurred in connection with this letter agreement, the other Transaction Documents, and
the transactions contemplated hereby and thereby, and (ii) your expenses incurred in connection with the activities contemplated by the registration rights agreement. 
 (h) Successors and Assigns. Except as otherwise expressly provided herein, the provisions hereof shall inure to the benefit of, and be binding
upon, the Company’s successors and assigns and your successors and assigns, and no other person; provided, that, no party may assign this letter agreement, or any of its rights or obligations hereunder, without the written consent of the other
party hereto. 
 (i) Waiver. It is understood and agreed that no failure or delay by a party hereto in exercising any right, power or
privilege hereunder shall operate as a waiver thereof, nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any right, power or privilege hereunder. 
 (j) Severability. If any provision of this Agreement is determined to be invalid, illegal, or unenforceable, the remaining provisions of this
Agreement shall remain in full force and effect provided that the economic and legal substance of, the Transaction is not affected in any manner materially adverse to any party. In the event of any such determination, the parties agree to negotiate
in good faith to modify this Agreement to fulfill as closely as possible the original intent and purpose hereof. To the extent permitted by law, the parties hereby to the same extent waive any provision of law that renders any provision hereof
prohibited or unenforceable in any respect. 
 (k) Specific Performance. The parties hereto acknowledge and agree that money damages
would not be a sufficient remedy for any breach or threatened breach of any provision of this letter agreement, and that in addition to all other remedies which we or the Company may have, each of the parties hereto will be entitled to seek specific
performance and injunctive or other equitable relief as a remedy for any such breach, without the necessity of posting any bond. 
  

 11 








 If the foregoing accurately reflects our agreement, please sign and return a copy of this letter to me on
behalf of the Company. 
  

			
	Sincerely yours,
	
	AmeriCredit Corp.
		
	By:	 	  

	Name:	 	  

	Title:	 	  



 Agreed to: 
  

			
	Fairholme Funds, Inc.
		
	By:	 	  

	Name:	 	  

	Title:	 	  


 [Signature Page to Exchange Agreement] 







 Exhibit A 







 Exhibit B-1 
  


 14 








 December     , 2008 
 AmeriCredit Corp. 
 801 Cherry Street 
 Suite 3900 
 Fort Worth, Texas 76102 
 Attn: Daniel E. Berce, President and Chief Executive Officer 
 Ladies and
Gentlemen: 
 We have entered into an Exchange Agreement, dated as of November 24, 2008, with AmeriCredit Corp., a Texas corporation (the
“Company”), to acquire shares of common stock, $.01 par value per share (the “Common Stock”), of the Company (the “Exchange Agreement”). In consideration for entering into the Exchange Agreement and
for the Company’s forbearing the enactment of certain shareholder protection measures at the present time, and without prejudice to the Company’s enactment of such measures in the future, intending to be legally bound, we agree as follows:

 1. We agree that, until December 31, 2010, without the prior approval of a majority of the members of the Board of Directors of the
Company (the “Board”) who are not Affiliates of ours and who have not been nominated to serve on the Board by us or any of our Affiliates or Associates (the “Disinterested Directors”), we, the advisory accounts
(both now existing and those created subsequent to the date hereof) through which Fairholme Capital Management, L.L.C. (or any related or affiliated person or persons) beneficially owns (within the meaning of Section 13(d) of the Exchange Act)
Common Stock, our Affiliates, and any persons with whom we shall have formed a “group” (within the meaning of Section 13(d)(3) of the Exchange Act), but excluding those personal and family accounts of the managing member of Fairholme
Capital Management, L.L.C. which hold Common Stock of the Company as of the date hereof, (together, the “Restricted Persons”) will not (i) enter into or agree, offer, seek or propose to enter into, directly or indirectly, any
merger, acquisition transaction or other business combination, recapitalization, or restructuring involving the Company or any of its subsidiaries or any of their respective assets or properties; (ii) make, or in any way participate in,
directly or indirectly, any “solicitation” of “proxies” (as such terms are used in the proxy rules of the Securities and Exchange Commission promulgated under the Exchange Act) to vote, or seek to advise or influence any person
with respect to the voting of, any voting securities of the Company or any of its subsidiaries in connection with seeking the removal of any directors on the Board or a change in the size or composition of the Board, or call a special
shareholders’ meeting for any such purpose; or (iii) directly or indirectly enter into any discussions, negotiations, arrangements 

  

 15 








 
or understandings with any other person (including any individual, firm, corporation, partnership or other entity or any “person” as such term is
used in Section 13(d) or Section 14(d)(2) of the Exchange Act) (“person”) with respect to any of the foregoing activities or propose any of such activities. The “Exchange Act” means the Securities Exchange
Act of 1934, as amended, or any successor statute. The term “Affiliate” shall have the meaning set forth in Rule 12b-2 of the General Rules and Regulations under the Exchange Act. 
 2. We acknowledge that the Restricted Persons have acquired shares of Common Stock of the Company representing approximately
[    %] of the outstanding Common Stock, and will acquire additional shares of Common Stock pursuant to the Exchange Agreement that will increase their collective ownership of the outstanding Common Stock to approximately
[    %], and, until December 31, 2010, without the prior approval of a majority of the Disinterested Directors, we agree that the Restricted Persons will not acquire any additional shares of Common Stock (or rights in
respect thereof) or the right or rights to acquire or vote additional voting securities of the Company if, as a result thereof, the Restricted Persons would have beneficial ownership (within the meaning of Section 13(d) of the Exchange Act) of
in excess of [    %] of the voting power of the Common Stock. In no event shall the Restricted Persons acquire any additional shares of Common Stock or right or rights to acquire additional shares of Common Stock unless
(i) at such time there is no default or event of default under any of the Company’s or any of its subsidiaries’ warehouse credit facility agreements or securitization transaction agreements, and (ii) any such acquisition of
additional Common Stock or right or rights to acquire additional shares of Common Stock by the Restricted Persons would not result in the occurrence of a default or an event of default under any such agreement. Subject to the limitations and
restrictions contained in clauses (i) and (ii) of the previous sentence, the Restricted Persons may acquire additional shares of Common Stock (or rights in respect thereof) or the right or rights to acquire or vote additional voting
securities of the Company (a) pursuant to the preemptive rights provided pursuant to the Exchange Agreement, (b) in the event any other person or group (of which such person is a part) that is unaffiliated with the Restricted Persons
acquires more than 30% of the voting power of the Common Stock, in which case the Restricted Persons shall then be permitted to acquire such number of additional shares of Common Stock that would permit them to beneficially own an aggregate amount
of Common Stock having voting power equal to the voting power of such unaffiliated person, entity or group less [    %], such that they own in the aggregate up to [    %] less than the
Company’s largest shareholder, or (c) in any rights offering conducted by the Company in which any current holders of the Company’s securities are offered the opportunity, on a pro rata basis, to acquire shares or other securities,
voting or non-voting, of the Company. 
 3. We agree that, until December 31, 2010, without the prior approval of a majority of the
Disinterested Directors, the Restricted Persons will not sell or dispose, in a single transaction or series of transactions, Common Stock (or rights in respect thereof) to any other person or “group” if we know the person or group would
hold (for such purpose, including the right to acquire) in excess of 4.9% of the Common Stock, unless (i) prior to such sale or disposition, the proposed transferee enters into an agreement with the Company in substantially the form of this
letter agreement (other than Paragraph 6); (ii) such sale is part of a tender offer or exchange offer made to all stockholders of the Company by a person other than us or who is not a subsidiary or an Affiliate of ours and is not
a part of a “group” of which we are a part; or (iii) such disposition is pursuant to a dividend or distribution made by us on a pro rata basis to our shareholders. 
  

 16 








 4. The restrictions set forth in Paragraph 2 hereof are expressly agreed to preclude us from engaging in
any hedging or other transaction which is or would result in the acquisition of “beneficial ownership” (as defined in Rule 13d-3 of the Exchange Act) of Common Stock in contravention of the provisions of this letter agreement. Such
prohibited hedging or other transactions would include, without limitation, any purchase, sale or grant of any right (including, without limitation, any put or call option) with respect to Common Stock or with respect to any security that includes,
relates to, or derives any significant part of its value from such Common Stock. 
 5. We agree that until December 31, 2010, at any
meeting of the shareholders of the Company, however called, or in any other circumstance in which the vote, consent or approval of the shareholders of the Company, in their capacity as shareholders, is sought, with respect to the election or removal
of directors of the Company, that we shall vote, give our consent or withhold our vote with respect thereto, or cause to be voted or withheld from voting or cause consent to be given or not given with respect thereto, all shares of Common Stock held
by the Restricted Persons, or over which we exercise voting control, in favor of those nominees approved by the Disinterested Directors, provided, if we have become and remain entitled to designate an individual for election to the Board in
accordance with Paragraph 6, the foregoing shall only apply if our nominee shall have been nominated to serve on the Board upon the expiration of his or her term of office, if any such term is expiring, to the extent required under Paragraph 6. We
agree that, other than with respect to the proxy granted pursuant to this Paragraph 5, we will not grant any proxy, power-of-attorney or other authorization in or with respect to any shares of Common Stock that are held by the Restricted Persons, or
over which we exercise voting control, or take any other action, in our capacity as a shareholder of the Company, that would in any way restrict, limit or interfere with the performance of our obligations hereunder. We hereby revoke any previously
executed proxies and, until November     , 2013, hereby appoint Clifton H. Morris, Jr., with full power of substitution, our lawful proxy and attorney-in-fact, with respect to all shares of Common Stock beneficially owned
(as defined in Rule 13d-3 of the Exchange Act) by us in excess of [    %] of the outstanding shares of the Common Stock (as determined at the time immediately prior to the record date for determining shareholders entitled
to vote, take any action or give consent or, if there is no such record date, at the time immediately prior to the time for the taking of such vote or action or the giving of such consent), to vote, or take any other action, including giving any
consent or refraining from voting or giving any consent, in our capacity as shareholders of the Company on any matter submitted for vote, consent or approval of the shareholders of the Company, including, without limitation, any merger, acquisition
transaction or other business combination or plan of liquidation involving the Company or any of its subsidiaries or Affiliates or any of their respective assets or properties, the election or removal of the directors of the Company, and any other
matter or proposal submitted to the shareholders of the Company for their vote, consent or approval. THIS PROXY GRANTED HEREBY IS COUPLED WITH AN INTEREST AND IS IRREVOCABLE IN ACCORDANCE WITH SECTION 2.29C OF THE TEXAS BUSINESS CORPORATION ACT
OR ANY SUCCESSOR STATUTE. A counterpart of this letter agreement shall be deposited with the Company at its principal place of business or registered office and shall be subject to the same right of examination by shareholders of the Company, in
person or by attorney, as are the books and records of the Company. We agree that in the event that Clifton H. Morris, Jr., dies, is incapacitated or is no longer a member of the Board, then the irrevocable proxy hereby granted shall be exercisable
by Daniel E. Berce until the expiration of this irrevocable proxy or, if earlier, 

  

 17 








 
until such time as he dies, is incapacitated or is no longer a member of the Board, with the same force and effect as such has been granted to Clifton H.
Morris, Jr. In the event of the death, incapacity or ceasing to be a member of the Board of both Clifton H. Morris, Jr. and Daniel E. Berce, then the irrevocable proxy hereby granted herein shall be null and void effective immediately. The proxy
granted hereby shall terminate and automatically become null and void with respect to any shares of Common Stock transferred by us to a third party that is not an Affiliate of the Restricted Persons or to any person with whom the Restricted Persons
(or any one of them) has formed a “group”. 
 6. As a result of our acquisition of more than 20.0% of the outstanding Common Stock,
promptly following the consummation of the transactions contemplated by the Exchange Agreement, the Company shall increase the size of the Board by one (1) directorship, and the vacancy on the Board created thereby shall be filled by the
Disinterested Directors with one (1) of our designees to be selected by us in our sole discretion, who initially shall be Bruce Berkowitz. Such designee shall be appointed to the class of directors whose term expires at the 2009 annual meeting
of shareholders. In each subsequent election of directors of the Company, the Company shall use its best efforts to nominate a slate such that, when taken together with the directors not then up for re-election, the Board will include one
(1) director designated by us. If our director designee resigns or becomes ineligible to serve on the Board, we shall have the right, in our sole discretion, to designate a replacement for such director designee, provided such replacement is
eligible to serve on the Board. Upon our request, our director designee shall be appointed to serve on each committee of the Board, provided that such designee is qualified to serve on such committee under applicable regulations and listing
standards. The Company shall not increase the size of the Board beyond ten (10) directorships without the approval of both a majority of the members of the Board and our director designee. If, after having acquired beneficial ownership of at
least 20.0% of Common Stock, we (including our subsidiaries and Affiliates) subsequently sell or otherwise dispose of shares of Common Stock and, as a result, we (including our subsidiaries and Affiliates) shall beneficially own less than 20.0% of
the Common Stock, we shall cause the individual designated by us then serving on the Board to resign from the Board if requested by the Disinterested Directors and, subject to the proviso below, we shall no longer be entitled to representation on
the Board; provided, however, that if we purchase additional shares of Common Stock such that we again own 20.0% or more of the Common Stock within sixty (60) days of such request to resign by the Disinterested Directors, the individual
designated by us then serving on the Board shall not be required to resign and we shall continue to be entitled to representation on the Board pursuant to this letter agreement. 
 7. The Company shall furnish us with such financial information concerning the Company that we request to enable us to timely comply with our reporting
obligations under applicable securities laws. 
 8. The Company and we shall enter into a mutually acceptable registration rights agreement
having the principal terms set forth on Annex A hereto affording us the right to require the Company, at the Company’s expense, to file with the Securities and Exchange Commission, upon our demand, a registration statement on Form S-3
registering the resale of the shares of Common Stock owned by us. 
 9. We agree that all shares of Common Stock that we beneficially own as
of the date of this letter agreement, and any shares of Common Stock that we purchase or with respect to 

  

 18 








 
which we otherwise acquire beneficial ownership or voting rights, directly or indirectly, after the date of this letter agreement, including, without
limitation, shares acquired pursuant to the Exchange Agreement, or shares issued upon the conversion, exercise or exchange, as the case may be, of securities held by us that are convertible into, or exercisable or exchangeable for, shares of Common
Stock, shall be subject to the terms and conditions of this letter agreement. 
 10. The restrictions and agreements made by us contained in
Paragraphs 1 through 6 shall terminate upon the earliest to occur of (i) such time as the Restricted Persons own less than 5% of the Common Stock; (ii) the Company’s breach of any material provision of this letter agreement, which
breach shall continue uncured for more than 30 days after written notice of such breach shall have been delivered by us to the Disinterested Directors (but any such breach hereof by the Company shall not relieve the Company of the restrictions and
agreements made by it herein); (iii) the acquisition by any person or “group” that is not affiliated with us of a majority of the Common Stock; (iv) the date on which the Company shall have entered into any merger, acquisition
transaction or other business combination involving the Company or its assets or properties; (v) December 31, 2010; or (vi) the Company (a) commences any bankruptcy, reorganization, debt arrangement, or other case or proceeding
under any state or federal bankruptcy or insolvency law, (b) applies for, consents to, or acquiesces in, the appointment of a trustee, receiver or other custodian for the Company or a substantial part of its property, or makes a general
assignment for the benefit of creditors, under any state or federal bankruptcy or insolvency law, (c) has a trustee, receiver, or other custodian appointed for the Company or a substantial part of the Company’s property under any state or
federal bankruptcy or insolvency law, or (d) has a bankruptcy, reorganization, debt arrangement, or other case or proceeding under any state or federal bankruptcy or insolvency law, that is involuntarily commenced against or in respect of the
Company and which shall not have been dismissed within 30 days following the commencement thereof. The restrictions and obligations of the Company contained in Paragraphs 6 and 8 hereof shall terminate upon the earliest to occur of (i) if we
breach any material provision of this letter agreement, which breach shall continue uncured for more than 30 days after written notice of such breach shall have been delivered by the Company to us, but any such breach hereof by us shall not relieve
us of the restrictions and agreements made by us herein or (ii) December 31, 2010. Notwithstanding the foregoing, the provisions of Paragraph 7 hereof shall continue for so long as (but only to the extent that) we are required to include
financial information concerning the Company in our public reporting. 
 11. The parties hereto acknowledge and agree that money damages
would not be a sufficient remedy for any breach or threatened breach of any provision of this letter agreement, and that in addition to all other remedies which we or the Company may have, each of the parties hereto will be entitled to seek specific
performance and injunctive or other equitable relief as a remedy for any such breach, without the necessity of posting any bond. 
 12. It is
understood and agreed that no failure or delay by a party hereto in exercising any right, power or privilege hereunder shall operate as a waiver thereof, nor shall any single or partial exercise thereof preclude any other or further exercise thereof
or the exercise of any right, power or privilege hereunder. 
 13. The invalidity or unenforceability of any provision of this letter
agreement shall not affect the validity or enforceability of any other provisions of this letter agreement, which shall remain in full force and effect. 
  

 19 








 14. This letter agreement, including, without limitation, the provisions of this Paragraph 14, may not be
amended, modified, terminated or waived, in whole or in part, except upon the prior written approval of a majority of the Disinterested Directors and by a separate writing signed by the Company, if so authorized by the Disinterested Directors, and
us expressly so amending, modifying, terminating or waiving such agreement or any part hereof. Any such amendment, modification, termination or waiver of this letter agreement or any part hereof made without the prior written approval of the
Disinterested Directors shall be void and of no legal effect. 
 15. This letter agreement may be executed in two or more counterparts
(including by means of facsimile), each of which shall be deemed to be an original but all of which together shall constitute one and the same instrument. Receipt of an executed signature page to this letter agreement by facsimile or other
electronic transmission shall constitute effective delivery thereof. Electronic records of this executed letter agreement shall be deemed to be originals thereof. 
 16. Each party agrees and consents to personal jurisdiction and service of process and exclusive venue in the federal district court for the Northern District of Texas, Dallas Division, or the State of Texas for the
purposes of any action, suit or proceeding arising out of or relating to this letter agreement. This letter agreement shall be governed by, and construed in accordance with, the laws of the State of Texas, without regards to its conflicts of law
principles. 
  

			
	Very truly yours,
	
	Fairholme Funds, Inc.
		
	By:	 	  

	Name:	 	Bruce Berkowitz
	Title:	 	President
	
	Fairholme Capital Management, L.L.C.
	
	(on behalf of those advisory accounts, other than Fairholme Funds, Inc., included as Restricted Persons)


  

 20 









			
	By:	 	  

	Name:	 	
	Title:	 	


  

			
	Confirmed and agreed to as of the date first written above:
	
	AmeriCredit Corp.
		
	By:	 	  

	Name:	 	Daniel E. Berce
	Title:	 	President and Chief Executive Officer

  

 21 








 Annex A 
 Terms of Registrations Rights Agreement 
 Three demand registrations, subject to a minimum threshold of (i) at least 20%
of the aggregate number of shares held by us, or (ii) reasonably expected to generate aggregate gross proceeds of at least $25 million, even if less than 20%. 
 No more than one demand registration in any six month period. 
 The Company shall use its best efforts to
cause a registration statement to be filed not later than 30 days after receipt by the Company of the demand notice for a shelf registration (60 days for an underwritten offering); continuous effectiveness for 180 days. If available on Form S-3,
Company must file and maintain a shelf registration for the registrable shares (which include all currently owned and after acquired shares); shelf to remain effective so long as we own any shares; shelf to permit underwritten offerings and to the
extent available will be filed as a so-called “WKSI” shelf; securities to remain registrable unless they have been sold under a registration statement or Rule 144. 
 Blackout period: not more than once in any six-month period for not more than 60 days and not more than, in the aggregate, 90 days during any
twelve-month period. 
 The Company will pay all expenses in connection with any request for registration pursuant to the registration rights
agreement, including road shows. 
 Piggy back rights. 
 Most Favored Nations provision. 







 Exhibit B-2 
  


 2 








 November     , 2008 
 AmeriCredit Corp. 
 801 Cherry Street 
 Suite 3900 
 Fort Worth, Texas 76102 
 Attn: Daniel E. Berce, President and Chief Executive Officer 
 Ladies and
Gentlemen: 
 We have discussed with you our acquisition of shares of common stock, $.01 par value per share (the “Common
Stock”), of AmeriCredit Corp., a Texas corporation (the “Company”). In consideration for the Company’s forbearing the enactment of certain shareholder protection measures at the present time, and without prejudice to
the Company’s enactment of such measures in the future, and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, intending to be legally bound, we agree as follows: 
 1. We agree that, until December 31, 2010, without the prior approval of a majority of the members of the Board of Directors of the Company (the
“Board”) who are not Associates or Affiliates of ours and who have not been nominated to serve on the Board by us or any of our Affiliates or Associates (the “Disinterested Directors”), we, including, without
limitation, those personal accounts of the managing member of Fairholme Capital Management, L.L.C. (together, the “Restricted Persons”) will not (i) enter into or agree, offer, seek or propose to enter into, directly or
indirectly, any merger, acquisition transaction or other business combination, recapitalization, or restructuring involving the Company or any of its subsidiaries or any of their respective assets or properties; (ii) make, or in any way
participate in, directly or indirectly, any “solicitation” of “proxies” (as such terms are used in the proxy rules of the Securities and Exchange Commission promulgated under the Exchange Act) to vote, or seek to advise or
influence any person with respect to the voting of, any voting securities of the Company or any of its subsidiaries in connection with seeking the removal of any directors on the Board or a change in the size or composition of the Board, or call a
special shareholders’ meeting for any such purpose; or (iii) directly or indirectly enter into any discussions, negotiations, arrangements or understandings with any other person (including any individual, firm, corporation, partnership or
other entity or any “person” as such term is used in Section 13(d) or Section 14(d)(2) of the Exchange Act) (“person”) with respect to any of the foregoing activities or propose any of such 

  

 3 








 
activities. The “Exchange Act” means the Securities Exchange Act of 1934, as amended, or any successor statute. The terms
“Affiliate” and “Associate” shall have the meanings set forth in Rule 12b-2 of the General Rules and Regulations under the Exchange Act. 
 2. We acknowledge that the Restricted Persons have acquired 492,652 shares of Common Stock of the Company, and, until December 31, 2010, without the prior approval of a majority of the Disinterested Directors, we
agree that, the Restricted Persons will not acquire any additional shares of Common Stock (or rights in respect thereof) or the right or rights to acquire or vote additional voting securities of the Company, other than additional shares of Common
Stock (or rights in respect thereof) or the right or rights to acquire or vote additional voting securities of the Company that may be granted to Bruce Berkowitz in connection with any such grants made generally to members of the Board in connection
with their Board service; provided, however, the Restricted Persons may acquire additional shares of Common Stock (or rights in respect thereof) or the right or rights to acquire or vote additional voting securities of the Company in any rights
offering conducted by the Company in which any current holders of the Company’s securities are offered the opportunity, on a pro rata basis, to acquire shares or other securities, voting or non-voting, of the Company. 
 3. The restrictions set forth in Paragraph 2 hereof are expressly agreed to preclude us from engaging in any hedging or other transaction which is or
would result in the acquisition of “beneficial ownership” (as defined in Rule 13d-3 of the Exchange Act) of Common Stock in contravention of the provisions of this letter agreement. Such prohibited hedging or other transactions would
include, without limitation, any purchase, sale or grant of any right (including, without limitation, any put or call option) with respect to Common Stock or with respect to any security that includes, relates to, or derives any significant part of
its value from such Common Stock. 
 4. We agree that until December 31, 2010, at any meeting of the shareholders of the Company,
however called, or in any other circumstance in which the vote, consent or approval of the shareholders of the Company, in their capacity as shareholders, is sought, with respect to the election or removal of directors of the Company, that we shall
vote, give our consent or withhold our vote with respect thereto, or cause to be voted or withheld from voting or cause consent to be given or not given with respect thereto, all shares of Common Stock held by the Restricted Persons, or over which
we exercise voting control, in favor of those nominees approved by the Disinterested Directors, provided, if Fairholme Funds, Inc. and Fairholme Capital Management, L.L.C. (collectively, “Fairholme”) have become and remain entitled
to designate an individual for election to the Board in accordance with the provisions of that certain letter agreement, dated the date hereof, by and among Fairholme and the Company (the “Fairholme Letter”), that Fairholme’s
nominee shall have been nominated to serve on the Board upon the expiration of his or her term of office, if any such term is expiring, to the extent required under the Fairholme Letter. We agree that we will not grant any proxy, power-of-attorney
or other authorization in or with respect to any shares of Common Stock that are held by the Restricted Persons, or over which we exercise voting control, or take any other action, in our capacity as a shareholder of the Company, that would in any
way restrict, limit or interfere with the performance of our obligations hereunder. 
  

 4 








 5. The Company shall furnish us with such financial information concerning the Company that we request to
enable us to timely comply with our reporting obligations under applicable securities laws. 
 6. We agree that all shares of Common Stock
that we beneficially own as of the date of this letter agreement, and any shares of Common Stock that we purchase or with respect to which we otherwise acquire beneficial ownership or voting rights, directly or indirectly, after the date of this
letter agreement, including, without limitation, shares issued upon the conversion, exercise or exchange, as the case may be, of securities held by us that are convertible into, or exercisable or exchangeable for, shares of Common Stock, shall be
subject to the terms and conditions of this letter agreement. 
 7. The restrictions and agreements made by us contained in Paragraphs 1
through 4 shall terminate upon the termination of the restrictions contained in paragraphs 1 through 6 of the Fairholme Letter in accordance with the terms of the Fairholme Letter. The restrictions and obligations of the Company contained in
Paragraph 5 hereof shall terminate upon the earliest to occur of (i) if we breach any material provision of this letter agreement, which breach shall continue uncured for more than 30 days after written notice of such breach shall have been
delivered by the Company to us, but any such breach hereof by us shall not relieve us of the restrictions and agreements made by us herein or (ii) December 31, 2010. Notwithstanding the foregoing, the provisions of Paragraph 5 hereof shall
continue for so long as (but only to the extent that) we are required to include financial information concerning the Company in our public reporting. 
 8. The parties hereto acknowledge and agree that money damages would not be a sufficient remedy for any breach or threatened breach of any provision of this letter agreement, and that in addition to all other remedies
which we or the Company may have, each of the parties hereto will be entitled to seek specific performance and injunctive or other equitable relief as a remedy for any such breach, without the necessity of posting any bond. 
 9. It is understood and agreed that no failure or delay by a party hereto in exercising any right, power or privilege hereunder shall operate as a waiver
thereof, nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any right, power or privilege hereunder. 
 10. The invalidity or unenforceability of any provision of this letter agreement shall not affect the validity or enforceability of any other provisions of this letter agreement, which shall remain in full force and
effect. 
 11. This letter agreement, including, without limitation, the provisions of this Paragraph 11, may not be amended, modified,
terminated or waived, in whole or in part, except upon the prior written approval of a majority of the Disinterested Directors and by a separate writing signed by the Company, if so authorized by the Disinterested Directors, and us expressly so
amending, modifying, terminating or waiving such agreement or any part hereof. Any such amendment, modification, termination or waiver of this letter agreement or any part hereof made without the prior written approval of the Disinterested Directors
shall be void and of no legal effect. 
  

 5 








 12. This letter agreement may be executed in two or more counterparts (including by means of facsimile),
each of which shall be deemed to be an original but all of which together shall constitute one and the same instrument. Receipt of an executed signature page to this letter agreement by facsimile or other electronic transmission shall constitute
effective delivery thereof. Electronic records of this executed letter agreement shall be deemed to be originals thereof. 
 13. Each party
agrees and consents to personal jurisdiction and service of process and exclusive venue in the federal district court for the Northern District of Texas, Dallas Division, or the State of Texas for the purposes of any action, suit or proceeding
arising out of or relating to this letter agreement. This letter agreement shall be governed by, and construed in accordance with, the laws of the State of Texas, without regards to its conflicts of law principles. 
  

			
	Very truly yours,
	
	  

	Tracey Berkowitz
	
	  

	Bruce Berkowitz
	
	The Fairholme Foundation
		
	By:	 	  

	Name:	 	  

	Title:	 	  



  

 6 









			
	East Lane, LLC
		
	By:	 	  

	Name:	 	  

	Title:	 	  



  

			
	Confirmed and agreed to as of the date first written above:
	
	AmeriCredit Corp.
		
	By:	 	  

	Name:	 	Daniel E. Berce
	Title:	 	President and Chief Executive Officer

  

 7 








 Exhibit C 
  

 8 








 REGISTRATION RIGHTS AGREEMENT 
 REGISTRATION RIGHTS AGREEMENT, dated as of December [    ], 2008, by and between AmeriCredit Corp., a Texas corporation
(the “Company”), and Fairholme Funds, Inc., a Maryland corporation (“Fairholme”). 
 WHEREAS,
the Company has agreed to provide Fairholme and its transferees and assigns certain rights as set forth herein. 
 NOW, THEREFORE, in
consideration of the premises and of the mutual covenants and obligations hereinafter set forth (and for other good and valuable consideration the receipt and sufficiency of which are hereby acknowledged by the Company), the parties hereto hereby
agree as follows: 
 ARTICLE I 
 DEFINITIONS 
 Section 1.1. Certain Defined Terms. As used herein, the following terms shall have the following meanings:

 “Action” means any legal, administrative, regulatory or other suit, action, claim, audit, assessment, arbitration
or other proceeding, investigation or inquiry. 
 “Agreement” means this Registration Rights Agreement as it may be
amended, supplemented, restated or modified from time to time. 
 “Beneficial Ownership” by a Person of any
securities includes ownership by any Person who, directly or indirectly, through any contract, arrangement, understanding, relationship or otherwise, has or shares (i) voting power which includes the power to vote, or to direct the voting of,
such security; and/or (ii) investment power which includes the power to dispose, or to direct the disposition, of such security; and shall otherwise be interpreted in accordance with the term “beneficial ownership” as defined in Rule
13d-3 adopted by the SEC under the Exchange Act. The term “Beneficially Own” shall have a correlative meaning. 
 “Business Day” means any day, other than a Saturday, Sunday or a day on which banking institutions in New York, New York are authorized or obligated to close. 
 “Common Stock” means the shares of Common Stock, par value $0.01 per share, of the Company. 
 “Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated by the SEC from
time to time thereunder. 
 “Governmental Entity” shall mean any court, administrative agency or commission or other
governmental authority or instrumentality, whether federal, state, local or foreign and any applicable industry self-regulatory organization. 
  

 9 








 “Holders” means Fairholme and any Transferee of Registrable Securities (and
“Holder” means any of such Persons). 
 “Holders’ Representative” means Fairholme or any
or any other Holder designated by Fairholme as the Holders’ Representative. 
 “Issuer Free Writing Prospectus”
means an issuer free writing prospectus, as defined in Rule 433 under the Securities Act, relating to an offer of the Registrable Securities. 
 “Law” means any statute, law, code, ordinance, rule or regulation of any Governmental Entity. 
 “Other Securities” means shares of Common Stock other than Registrable Securities. 
 “Person” means any individual, corporation, limited liability company, limited or general partnership, joint venture, association, joint stock company, trust, unincorporated organization, government or any agency or
political subdivisions thereof or any group (within the meaning of Section 13(d)(3) of the Exchange Act) comprised of two or more of the foregoing. 
 “Prospectus” means the prospectus included in any Registration Statement (including a prospectus that discloses information previously omitted from a prospectus filed as part of an effective
Registration Statement in reliance upon Rule 430A or Rule 430B promulgated under the Securities Act), as amended or supplemented by any prospectus supplement with respect to the terms of the offering of any portion of the Registrable Securities
covered by such Registration Statement, any Issuer Free Writing Prospectus related thereto, and all other amendments and supplements to such prospectus, including post-effective amendments, and all material incorporated by reference or deemed to be
incorporated by reference in such prospectus. 
 “Registrable Securities” means (a) all shares of Common Stock
owned by Fairholme and its Subsidiaries, as of the date of this Agreement, and all shares of Common Stock acquired by Fairholme and its Subsidiaries, on, and from and after, the date of this Agreement, and (b) any securities issued directly or
indirectly with respect to such shares described in clause (a) because of stock splits, stock dividends, reclassifications, recapitalizations, mergers, consolidations, or similar events. As to any particular Registrable Securities, once issued
such securities shall cease to be Registrable Securities when (i) a Registration Statement with respect to the sale of such securities shall have become effective under the Securities Act and such securities shall have been disposed of in
accordance with such Registration Statement or (ii) such securities shall have been sold to the public pursuant to Rule 144 (or any successor provision) under the Securities Act. 
 “Registration Statement” means any registration statement of the Company under the Securities Act which permits the public
offering of any of the Registrable Securities pursuant to the provisions of this Agreement, including the Prospectus, amendments and supplements to such registration statement, including post-effective amendments, all exhibits and all material
incorporated by reference or deemed to be incorporated by reference in such registration statement. 
 “Rule 144”
means Rule 144 under the Securities Act (or any successor provision). 
  

 10 








 “SEC” means the United States Securities and Exchange Commission. 
 “Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated by the SEC from time to
time thereunder. 
 “Selling Holder” means each Holder of Registrable Securities included in a registration pursuant
to Article II. 
 “Subsidiary” of any Person shall mean those corporations and other entities of which such Person
owns or controls more than 50% of the outstanding equity securities either directly or through an unbroken chain of entities as to each of which more than 50% of the outstanding equity securities is owned directly or indirectly by its parent.

 “Transfer” means, directly or indirectly, to sell, transfer, assign, pledge, encumber, hypothecate or similarly
dispose of, or to enter into any contract, option or other arrangement or understanding with respect to the sale, transfer, assignment, pledge, encumbrance, hypothecation or similar disposition. 
 “Transferee” means any of (i) the transferee of all or any portion of the Registrable Securities held by Fairholme, or
(ii) the subsequent transferee of all or any portion of the Registrable Securities held by any Transferee; provided, that no Transferee shall be entitled to any benefits of a Transferee hereunder unless such Transferee executes and
delivers to the Company an instrument substantially in the form provided as Exhibit A attached hereto. 
 (a) Terms Generally.
The definitions in Section 1.1 shall apply equally to both the singular and plural forms of the terms defined. Whenever the context may require, any pronoun shall include the corresponding masculine, feminine and neuter forms. The words
“include”, “includes” and “including” shall be deemed to be followed by the phrase “without limitation”, unless the context expressly provides otherwise. All references herein to Articles, Sections,
paragraphs, subparagraphs, clauses or Exhibits shall be deemed references to Articles, Sections, paragraphs, subparagraphs or clauses of, or Exhibits to, this Agreement, unless the context requires otherwise. Unless otherwise expressly defined,
terms defined in this Agreement have the same meanings when used in any Exhibit hereto. Unless otherwise specified, the words “this Agreement”, “herein”, “hereof”, “hereto” and “hereunder” and other
words of similar import refer to this Agreement as a whole (including the Exhibits) and not to any particular provision of this Agreement. The term “or” is not exclusive. The word “extent” in the phrase “to the extent”
shall mean the degree to which a subject or other thing extends, and such phrase shall not mean simply “if”. Unless expressly stated otherwise, any Law defined or referred to herein means such Law as from time to time amended, modified or
supplemented, including by succession of comparable successor Laws and references to all attachments thereto and instruments incorporated therein. References to a Person are also to its permitted successors and assigns. The headings contained in
this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement. 
  

 11 








 ARTICLE II 
 REGISTRATION RIGHTS 
 Section 2.1. Demand Registrations. (a) At any time and from
time to time, the Holders’ Representative shall have the right by delivering one or more written notices to the Company (each, a “Demand Notice”) to require the Company to, pursuant to the terms of this Agreement,
register under and in accordance with the provisions of the Securities Act the number of Registrable Securities owned by Holders and requested by such Demand Notice to be so registered (a “Demand Registration”); provided,
however, that a Demand Notice may only be made if the amount of Registrable Securities requested to be registered is either (i) at least 20% of the aggregate number of Registrable Securities then held by all Holders or (ii) reasonably
expected to generate aggregate gross proceeds on sale (prior to deducting underwriting discounts and commissions and offering expenses) of at least $25 million. A Demand Notice shall also specify the expected method or methods of disposition of the
applicable Registrable Securities. Following receipt of a Demand Notice, the Company shall file, as promptly as reasonably practicable, but not later than, 60 days with respect to any underwritten offering, or 30 days with respect to any other
offering, after receipt by the Company of such Demand Notice (subject to paragraph (e) of this Section 2.1), a Registration Statement relating to the offer and sale of the Registrable Securities requested to be included therein by the
Holders thereof in accordance with the methods of distribution elected by such Holders (a “Demand Registration Statement”) and shall use its reasonable best efforts to cause such Registration Statement to be declared
effective under the Securities Act as promptly as practicable after the filing thereof. 
 (b) No securities shall be included under any
Demand Registration Statement related to an underwritten offering without the written consent of the Holders’ Representative, except Registrable Securities requested to be included therein pursuant to Section 2.1(a). Subject to the
preceding sentence, if any of the Registrable Securities registered pursuant to a Demand Registration are to be sold in a firm commitment underwritten offering, and the managing underwriter(s) of such underwritten offering advise the Holders in
writing that it is their good faith opinion that the total number or dollar amount of Registrable Securities proposed to be sold in such offering, together with any Other Securities proposed to be included by holders thereof which are entitled to
include securities in such Registration Statement, exceeds the total number or dollar amount of such securities that can be sold without having an adverse effect on the amount, price, timing or distribution of the Registrable Securities to be so
included together with all such Other Securities, then there shall be included in such offering the number or dollar amount of Registrable Securities and such Other Securities that in the opinion of such managing underwriter(s) can be sold without
so adversely affecting such offering, and such number of Registrable Securities and Other Securities shall be allocated for inclusion as follows: 
 (i) first, the Registrable Securities for which inclusion in such demand offering was requested by the Holders, pro rata (if applicable), based on the number of Registrable Securities Beneficially Owned by each such Holder; and

 (ii) second, among any holders of Other Securities, pro rata, based on the number of Other Securities Beneficially Owned by each
such holder. 
  

 12 








 (c) The Holders collectively shall be entitled to request no more than three Demand Registrations of the
Company, and in no event shall the Company be required to effect more than one Demand Registration in any six month period. 
 (d) In the
event of a Demand Registration, the Company shall use its reasonable best efforts to maintain the continuous effectiveness of the applicable Registration Statement for a period of at least one year after the effective date thereof or such shorter
period in which all Registrable Securities included in such Registration Statement have actually been sold. For the avoidance of doubt, the foregoing sentence is not intended to limit the obligation of the Company to maintain the continuous
effectiveness of the Short-Form Registration contemplated by Section 2.1(h) as required by Section 2.1(h). 
 (e) The Company shall
be entitled to postpone (but not more than once in any six-month period), for a reasonable period of time not in excess of 60 days (and not for periods exceeding, in the aggregate, 90 days during any twelve-month period), the filing or initial
effectiveness of, or suspend the use of, a Demand Registration Statement if the Company delivers to the Holders’ Representative a certificate signed by both the Chief Executive Officer and Chief Financial Officer of the Company certifying that,
in the good faith judgment of the Board of Directors of the Company, such registration, offering or use would reasonably be expected to materially adversely affect or materially interfere with any bona fide and imminent material financing of
the Company or any imminent material transaction under consideration by the Company or would require the disclosure of information that has not been, and is not otherwise required to be, disclosed to the public, the premature disclosure of which
would materially adversely affect the Company. 
 (f) The Holders’ Representative shall have the right to notify the Company that it has
determined that the Registration Statement relating to a Demand Registration be abandoned or withdrawn, in which event the Company shall promptly abandon or withdraw such Registration Statement. 
 (g) No request for registration will count for the purposes of the limitations in Section 2.1(c) if: (A) the Holders’ Representative
determines in good faith to withdraw the proposed registration prior to the effectiveness of the Registration Statement relating to such request due to marketing conditions or regulatory reasons relating to the Company, (B) the Registration
Statement relating to such request is not declared effective within 60 days of the date such Registration Statement is first filed with the SEC (other than solely by reason of the applicable Holders having refused to proceed), (C) prior to the
sale of at least 90% of the Registrable Securities included in the applicable registration relating to such request, such registration is adversely affected by any stop order, injunction or other order or requirement of the SEC or other Governmental
Entity or court, (D) more than 10% of the Registrable Securities requested by the Holders to be included in the registration are not so included pursuant to Section 2.1(b), or (E) the conditions to closing specified in any
underwriting agreement or purchase agreement entered into in connection with the registration relating to such request are not satisfied (other than as a result of a material default or breach thereunder by the applicable Holders). Notwithstanding
anything to the contrary, the Company will pay all expenses (in accordance with Section 2.8) in connection with any request for registration pursuant to this Agreement regardless of whether or not such request counts toward the limitation set
forth above. 
  

 13 








 (h) In addition to the foregoing, the Company will use its reasonable best efforts to remain qualified
for registration on Form S-3 (including, without limitation, if available, an automatic shelf registration statement for a “well-known seasoned issuer” as defined in Rule 405 under the Securities Act) or any comparable or successor
form or forms or any similar short-form registration (“Short-Form Registration”) and the Company shall file, as promptly as reasonably practicable after the execution and delivery of this Agreement, but not later than 30
days, such Short-Form Registration, which shall constitute a “shelf” registration statement providing for the registration of, and the sale on a continuous or delayed basis (notwithstanding anything to the contrary in Section 2.1(d))
of, the Registrable Securities, pursuant to Rule 415 under the Securities Act, to permit the distribution of the Registrable Securities in accordance with the methods of distribution elected by the Holders, including by means of an underwritten
offering. Upon filing a Short-Form Registration, the Company shall use its reasonable best efforts to keep such Short-Form Registration effective with the SEC at all times and any Short-Form Registration shall be re-filed upon its expiration, and
the Company shall cooperate in any shelf take-down by amending or supplementing the Prospectus related to such Short-Form Registration as may be reasonably requested by the Holders’ Representative or as otherwise required, until the Holders no
longer hold Registrable Securities (in each case, notwithstanding anything to the contrary in Section 2.1(d)). 
 Section 2.2
Piggyback Registrations. (a) If, other than pursuant to Section 2.1, the Company proposes or is required to file a registration statement under the Securities Act with respect to an offering of Common Stock, whether or not for sale
for its own account (other than a registration statement (i) on Form S-4, Form S-8 or any successor forms thereto, (ii) filed solely in connection with any employee benefit or dividend reinvestment plan, (iii) so long as a shelf
registration statement is effective and available pursuant to Section 2.1(h) hereof, filed solely in connection with the issuance or resale of Common Stock issuable upon conversion, exercise or exchange of any securities of the Company or any
of its Subsidiaries, where such convertible, exercisable or exchangeable securities were issued in, or as part of, a financing transaction, or (iv) filed pursuant to the terms of that certain warrant, dated September 25, 2008, issued by
the Company to Wachovia Investment Holdings, LLC), in a manner that would permit registration of Registrable Securities for sale to the public under the Securities Act, then the Company shall give prompt written notice of such proposed filing at
least 30 days before the anticipated filing date (the “Piggyback Notice”) to the Holders. The Piggyback Notice shall offer the Holders the opportunity to include in such registration statement the number of Registrable
Securities as they may request (a “Piggyback Registration”). Subject to Section 2.2(b) hereof, the Company shall include in each such Piggyback Registration all Registrable Securities with respect to which the Company
has received written requests for inclusion therein within 15 days after notice has been given to the Holders, to permit the distribution of such Registrable Securities in accordance with the methods of distribution elected by such Holders. The
Holders shall be permitted to withdraw all or part of the Registrable Securities from a Piggyback Registration at any time at least two Business Days prior to the effective date of the Registration Statement relating to such Piggyback Registration.
The Company shall use its reasonable best efforts to maintain the effectiveness of the Registration Statement for a Piggyback Registration for a period of at least one year after the effective date thereof or such shorter period in which all
Registrable Securities included in such Registration Statement have actually been sold. No Piggyback Registration shall count towards registrations required under Section 2.1. 
  

 14 








 (b) If any of the securities to be registered pursuant to the registration giving rise to the
Holders’ rights under this Section 2.2 are to be sold in an underwritten offering, the Holders shall be permitted to include all Registrable Securities requested to be included in such registration in such offering on the same terms and
conditions as any Other Securities included therein; provided, however, that if such offering involves a firm commitment underwritten offering and the managing underwriter(s) of such underwritten offering advise the Company in writing that it
is their good faith opinion that the total amount of Registrable Securities requested to be so included, together with all Other Securities that the Company and any other Persons having rights to participate in such registration intend to include in
such offering, exceeds the total number or dollar amount of such securities that can be sold without having an adverse effect on the price, timing or distribution of the Registrable Securities to be so included together with all Other Securities,
then there shall be included in such firm commitment underwritten offering the number or dollar amount of Registrable Securities and such Other Securities that in the opinion of such managing underwriter(s) can be sold without so adversely affecting
such offering, and such number of Registrable Securities and Other Securities shall be allocated for inclusion as follows: 
 (i) first, all
Other Securities being sold by the Company for its own account or by any Person (other than a Holder) exercising a contractual right to demand registration; 
 (ii) second, all Registrable Securities requested to be included by the Holders, pro rata (if applicable), based on the number of Registrable Securities Beneficially Owned by each such Holder; and 

(iii) third, among any other holders of Other Securities requesting such registration, pro rata, based on the number of Other Securities
Beneficially Owned by each such holder of Other Securities. 
 Section 2.3 Registration Procedures. If and whenever the Company
is required to use its efforts to effect the registration of any Registrable Securities under the Securities Act as provided in Article II, the Company shall effect such registration to permit the sale of such Registrable Securities in accordance
with the intended method or methods of disposition thereof, and pursuant thereto the Company shall cooperate in the sale of the securities and shall, as expeditiously as possible: 
 (a) Prepare and file with the SEC a Registration Statement or Registration Statements on such form which shall be available for the sale of the
Registrable Securities by the Holders or the Company in accordance with the intended method or methods of distribution thereof, and use its reasonable best efforts to cause such Registration Statement to become effective and to remain effective as
provided herein; provided, however, that before filing a Registration Statement or Prospectus or any amendments or supplements thereto (including documents that would be incorporated or deemed to be incorporated therein by reference), the
Company shall furnish or otherwise make available to the Selling Holders, their counsel and the managing underwriter(s), if any, copies of all such documents proposed to be filed, which documents will be subject to the reasonable review and comment
of such counsel, and such other documents reasonably requested by such counsel, including any comment letter from the SEC, and, if requested by such counsel, provide such counsel reasonable opportunity to participate in the preparation of such
Registration Statement and each Prospectus included therein and, upon execution of a customary 

  

 15 








 
confidentiality agreement, such other opportunities to conduct a reasonable investigation within the meaning of the Securities Act, including reasonable
access to the Company’s books and records, officers, accountants and other advisors. The Company shall not file any such Registration Statement or Prospectus or any amendments or supplements thereto (including such documents that, upon filing,
would be incorporated or deemed to be incorporated by reference therein) with respect to any registration pursuant to Section 2.1 or 2.2 to which the Holders’ Representative, its counsel, or the managing underwriter(s), if any, shall
reasonably object, in writing, on a timely basis, unless, in the opinion of the Company, such filing is necessary to comply with applicable Law. 
 (b) Prepare and file with the SEC such amendments and post-effective amendments to each Registration Statement as may be necessary to keep such Registration Statement continuously effective during the period provided herein and comply in
all material respects with the provisions of the Securities Act with respect to the disposition of all securities covered by such Registration Statement, and cause the related Prospectus to be supplemented by any Prospectus supplement or Issuer Free
Writing Prospectus as may be necessary to comply with the provisions of the Securities Act with respect to the disposition of the securities covered by such Registration Statement, and as so supplemented to be filed pursuant to Rule 424 (or any
similar provisions then in force) under the Securities Act. 
 (c) Notify each Selling Holder and the managing underwriter(s), if any,
promptly, and (if requested by any such Person) confirm such notice in writing, (i) when a Prospectus or any Prospectus supplement, Issuer Free Writing Prospectus or post-effective amendment has been filed, and, with respect to a Registration
Statement or any post-effective amendment, when the same has become effective, (ii) of any request by the SEC or any other Governmental Entity for amendments or supplements to a Registration Statement or related Prospectus or Issuer Free
Writing Prospectus or for additional information, (iii) of the issuance by the SEC of any stop order suspending the effectiveness of a Registration Statement or the initiation of any proceedings for that purpose, (iv) if at any time the
representations and warranties of the Company contained in any agreement (including any underwriting agreement contemplated by Section 2.3(o) below) cease to be true and correct, (v) of the receipt by the Company of any notification with
respect to the suspension of the qualification or exemption from qualification of any of the Registrable Securities for sale in any jurisdiction, or the initiation or threatening of any proceeding for such purpose, and (vi) of the happening of
any event that makes any statement made in such Registration Statement or related Prospectus or any document incorporated or deemed to be incorporated therein by reference or any Issuer Free Writing Prospectus related thereto untrue in any material
respect or that requires the making of any changes in such Registration Statement, Prospectus, documents or Issuer Free Writing Prospectus so that, in the case of the Registration Statement, it will not contain any untrue statement of a material
fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, not misleading, and that in the case of any Prospectus or Issuer Free Writing Prospectus, it will not contain any untrue statement of
a material fact or omit to state any material fact necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading. 
 (d) Use its reasonable best efforts to obtain the withdrawal of any order suspending the effectiveness of a Registration Statement, or the lifting of any
suspension of the qualification (or exemption from qualification) of any of the Registrable Securities for sale in any jurisdiction at the reasonably earliest practical date. 
  

 16 








 (e) If requested by the managing underwriter(s), if any, or the Holders of a majority of the Registrable
Securities being sold in connection with an underwritten offering, promptly include in a Prospectus supplement, post-effective amendment or Issuer Free Writing Prospectus such information as the managing underwriter(s), if any, or such Holders may
reasonably request in order to permit the intended method of distribution of such securities and make all required filings of such Prospectus supplement, such post-effective amendment or Issuer Free Writing Prospectus as soon as practicable after
the Company has received such request. 
 (f) Furnish or make available to each Selling Holder, and each managing underwriter, if any,
without charge, such number of conformed copies of the Registration Statement and each post-effective amendment thereto, including financial statements (but excluding schedules, all documents incorporated or deemed to be incorporated therein by
reference, and all exhibits, unless requested in writing by such Holder, counsel or managing underwriter(s)), and such other documents, as such Holders or such managing underwriter(s) may reasonably request, and upon request a copy of any and all
transmittal letters or other correspondence to or received from, the SEC or any other Governmental Entity relating to such offering. 
 (g)
Deliver to each Selling Holder, and the managing underwriter(s), if any, without charge, as many copies of the Prospectus or Prospectuses (including each form of Prospectus and any Issuer Free Writing Prospectus related to any such Prospectuses) and
each amendment or supplement thereto as such Persons may reasonably request in connection with the distribution of the Registrable Securities; and the Company, subject to Section 2.4(b), hereby consents to the use of such Prospectus and each
amendment or supplement thereto by each of the Selling Holders and the managing underwriter(s), if any, in connection with the offering and sale of the Registrable Securities covered by such Prospectus and any such amendment or supplement thereto.

 (h) Prior to any public offering of Registrable Securities, use its reasonable best efforts to register or qualify or cooperate with the
Selling Holders, the managing underwriter(s), if any, and their respective counsel in connection with the registration or qualification (or exemption from such registration or qualification) of such Registrable Securities for offer and sale under
the securities or “Blue Sky” laws of such jurisdictions within the United States as any Selling Holder or managing underwriter(s) reasonably requests in writing and to keep each such registration or qualification (or exemption therefrom)
effective during the period such Registration Statement is required to be kept effective and to take any other action that may be necessary or advisable to enable such Selling Holders to consummate the disposition of such Registrable Securities in
such jurisdiction; provided, however, that the Company will not be required to (i) qualify generally to do business in any jurisdiction where it is not then so qualified, (ii) subject itself to taxation in any such jurisdiction
where it is not then so subject, or (iii) take any action that would subject it to general service of process in any such jurisdiction where it is not then so subject. 
 (i) Cooperate with the Selling Holders and the managing underwriter(s), if any, to facilitate the timely preparation and delivery of certificates (not
bearing any legends) representing Registrable Securities to be sold after receiving written representations from each Selling Holder that the Registrable Securities represented by the certificates so delivered by such Selling Holder 

  

 17 








 
will be transferred in accordance with the Registration Statement, and enable such Registrable Securities to be in such denominations and registered in such
names as the managing underwriter(s), if any, or the Selling Holders may request at least two Business Days prior to any sale of Registrable Securities. 
 (j) Use its reasonable best efforts to cause the Registrable Securities covered by the Registration Statement to be registered with or approved by such other Governmental Entities within the United States, except as
may be required solely as a consequence of the nature of such Selling Holder’s business, in which case the Company will cooperate in all reasonable respects with the filing of such Registration Statement and the granting of such approvals, as
may be necessary to enable the seller or sellers thereof or the managing underwriter(s), if any, to consummate the disposition of such Registrable Securities. 
 (k) Upon the occurrence of any event contemplated by Section 2.3(c)(ii), (c)(iii), (c)(iv), (c)(v) or (c)(vi) above, prepare a supplement or post-effective amendment to the Registration Statement or a supplement
to the related Prospectus or any document incorporated or deemed to be incorporated therein by reference or an Issuer Free Writing Prospectus related thereto, or file any other required document so that, as thereafter delivered to the Selling
Holders, such Prospectus will not contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made,
not misleading. 
 (l) Prior to the effective date of the Registration Statement relating to the Registrable Securities, provide a CUSIP
number for the Registrable Securities. 
 (m) Provide and cause to be maintained a transfer agent and registrar for all Registrable
Securities covered by such Registration Statement from and after a date not later than the effective date of such Registration Statement. 
 (n) Use its reasonable best efforts to cause all shares of Registrable Securities covered by such Registration Statement to be authorized to be listed on each national securities exchange, if any, on which similar securities issued by the
Company are then listed, and use its reasonable best efforts to maintain any such listing in effect. 
 (o) Enter into such agreements
(including an underwriting agreement in form, scope and substance as is customary in underwritten offerings) and take all such other actions reasonably requested by the Holders of a majority of the Registrable Securities being sold in connection
therewith or by the managing underwriter(s), if any, to expedite or facilitate the disposition of such Registrable Securities, and in connection therewith, whether or not an underwriting agreement is entered into and whether or not the registration
is an underwritten registration, (i) make such representations and warranties to the Selling Holders and the managing underwriter(s), if any, with respect to the business of the Company and its Subsidiaries, and the Registration Statement,
Prospectus and documents, if any, incorporated or deemed to be incorporated by reference therein, in each case, in form, substance and scope as are customarily made by issuers in underwritten offerings, and, if true, confirm the same if and when
requested, (ii) use its reasonable best efforts to furnish to the Selling Holders of such Registrable Securities opinions of counsel to the Company and updates thereof (which counsel and opinions (in form, scope and substance) shall be 

  

 18 








 
reasonably satisfactory to the managing underwriter(s), if any, and counsels to the Selling Holders of the Registrable Securities), addressed to each Selling
Holder of Registrable Securities and each of the managing underwriter(s), if any, covering the matters customarily covered in opinions requested in underwritten offerings and such other matters as may be reasonably requested by such counsel and
managing underwriter(s), (iii) use its reasonable best efforts to obtain “comfort” letters and updates thereof from the independent certified public accountants of the Company (and, if necessary, any other independent certified public
accountants of any Subsidiary of the Company or of any business acquired by the Company for which financial statements and financial data are, or are required to be, included in the Registration Statement) who have certified the financial statements
included in such Registration Statement, addressed to each Selling Holder of Registrable Securities (unless such accountants shall be prohibited from so addressing such letters by applicable standards of the accounting profession) and each of the
managing underwriter(s), if any, such letters to be in customary form and covering matters of the type customarily covered in “comfort” letters in connection with underwritten offerings, (iv) if an underwriting agreement is entered
into, the same shall contain indemnification provisions and procedures substantially to the effect set forth in Section 2.5 hereof with respect to all parties to be indemnified pursuant to said Section except as otherwise agreed by the Holders
of a majority of the Registrable Securities being sold in connection therewith and the managing underwriter(s), if any, and (v) deliver such documents and certificates as may be reasonably requested by the Holders of a majority of the
Registrable Securities being sold in connection therewith, their counsel and the managing underwriter(s), if any, to evidence the continued validity of the representations and warranties made pursuant to clause (i) above and to evidence
compliance with any customary conditions contained in the underwriting agreement or other agreement entered into by the Company. The above shall be done at each closing under such underwriting or similar agreement, or as and to the extent required
thereunder. 
 (p) Upon execution of a customary confidentiality agreement, make available for inspection by a representative of the Selling
Holders, the managing underwriter(s), if any, and any attorneys or accountants retained by such Selling Holders or managing underwriter(s), at the offices where normally kept, during reasonable business hours, financial and other records, pertinent
corporate documents and properties of the Company and its Subsidiaries, and cause the officers, directors and employees of the Company and its Subsidiaries to supply all information in each case reasonably requested by any such representative,
managing underwriter(s), attorney or accountant in connection with such Registration Statement. 
 (q) Cause its officers to use their
reasonable best efforts to support the marketing of the Registrable Securities covered by the Registration Statement (including, without limitation, by participation in “road shows”) taking into account the Company’s business needs.

 (r) Otherwise use its reasonable best efforts to comply with all applicable rules and regulations of the SEC and any applicable national
securities exchange, and make available to its security holders, as soon as reasonably practicable (but not more than 18 months) after the effective date of the registration statement, an earnings statement which shall satisfy the provisions of
Section 11(a) of the Securities Act. 
  

 19 








 Section 2.4 Certain Additional Agreements. 
 (a) The Company may require each Selling Holder to furnish to the Company in writing such information required in connection with such registration
regarding such Selling Holder and the distribution of such Registrable Securities as the Company may, from time to time, reasonably request in writing and the Company may exclude from such registration the Registrable Securities of any Selling
Holder who fails to furnish such information within a reasonable time after receiving such request. 
 (b) Each Selling Holder agrees that
upon receipt of any notice from the Company of the happening of any event of the kind described in Section 2.3(c)(iii) or (c)(vi) hereof, such Holder will forthwith discontinue disposition of such Registrable Securities covered by such
Registration Statement or Prospectus until such Holder’s receipt of the copies of the supplemented or amended Prospectus contemplated by Section 2.3(k) hereof, or until it is advised in writing by the Company that the use of the applicable
Prospectus may be resumed, and has received copies of any additional or supplemental filings that are incorporated or deemed to be incorporated by reference in such Prospectus; provided, however, that (i) in no event shall such
discontinuance exceed the time period set forth in Section 2.1(e) hereof, and (ii) the Company shall extend the time periods under Section 2.1 and Section 2.2 with respect to the length of time that the effectiveness of a
Registration Statement must be maintained by the amount of time the Holder is required to discontinue disposition of such securities. 
 (c)
The Company shall not enter into any agreement with respect to any equity securities that grants or provides holders of such securities with registration rights that have terms more favorable than the registration rights granted to holders of the
Registrable Securities in this Agreement unless similar rights are granted to holders of Registrable Securities. The Company shall provide the Holders’ Representative with a copy of any such agreement promptly after its execution and the
Holders’ Representative shall notify the Company within 60 days thereafter of such more favorable terms. The failure of the Holders’ Representative to so notify the Company shall not release, waive or otherwise affect the Company’s
obligations pursuant to this Section 2.4(c), except to the extent that the Company is prejudiced as a result of such failure. 
 (d)
Each Holder covenants and agrees that it will comply with the prospectus delivery requirements of the Securities Act as applicable to it or an exemption therefrom in connection with sale of Registrable Securities pursuant to the Registration
Statement. 
 (e) If requested by the Holders, the Company shall cooperate with the Holders to facilitate the timely preparation and delivery
of certificates representing Registrable Securities to be delivered to a transferee pursuant to a Registration Statement, which certificates shall be free of all restrictive legends (other than those required by applicable law), and to enable such
Registrable Securities to be in such denominations and registered in such names as any such Holders may request. 
 Section 2.5.
Indemnification. 
 (a) Indemnification by the Company. The Company shall indemnify and hold harmless, to the fullest extent
permitted by Law, each Selling Holder whose Registrable Securities 

  

 20 








 
are covered by a Registration Statement or Prospectus, the officers, directors, partners (limited and general), members, managers, shareholders, accountants,
attorneys, agents and employees of each of them, each Person who controls (within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act) each such Selling Holder and the officers, directors, partners (limited
and general), members, managers, shareholders, accountants, attorneys, agents and employees of each such controlling Person, each underwriter (including any Holder that is deemed to be an underwriter pursuant to any SEC comments or policies), if
any, and each Person who controls (within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act) such underwriter (collectively, “Holder Indemnitees”), from and against any and all
losses, claims, damages, liabilities, expenses (including, without limitation, costs of preparation and reasonable attorneys’ fees and any other reasonable fees or expenses incurred by such party in connection with any investigation or Action),
judgments, fines, penalties, charges and amounts paid in settlement (collectively, “Losses”), as incurred, arising out of or based upon any untrue statement (or alleged untrue statement) of a material fact contained in any
applicable Registration Statement (or in any preliminary or final Prospectus contained therein, any document incorporated by reference therein or Issuer Free Writing Prospectus related thereto) or any other offering circular, amendment of or
supplement to any of the foregoing or other document incident to any such registration, qualification, or compliance, or based on any omission (or alleged omission) to state therein (in the case of a final or preliminary Prospectus, in light of the
circumstances under which they were made) a material fact required to be stated therein or necessary to make the statements therein not misleading, or any violation by the Company of the Securities Act or of the Exchange Act in connection with any
such registration, qualification, or compliance; provided, that the Company will not be liable to a Selling Holder or underwriter, as the case may be, in any such case to the extent that any such Loss arises out of or is based on any untrue
statement or omission by such Selling Holder or underwriter, as the case may be, but only to the extent, that such untrue statement (or alleged untrue statement) or omission (or alleged omission) is made in such Registration Statement (or in any
preliminary or final Prospectus contained therein, any document incorporated by reference therein or Issuer Free Writing Prospectus related thereto), offering circular, amendment of or supplement to any of the foregoing or other document in reliance
upon and in conformity with written information furnished to the Company by such Selling Holder or underwriter specifically for inclusion in such document; and provided, further, that the Company will not be liable to any Person who
participates as an underwriter in any underwritten offering or sale of Registrable Securities, or to any Person who is a selling Holder in any non-underwritten offering or sale of Registrable Securities, or any other Person, if any, who controls
such underwriter or selling Holder within the meaning of the Securities Act, under the indemnity agreement in this Section 2.5 with respect to any preliminary Prospectus or the final Prospectus (including any amended or supplemented preliminary
or final Prospectus), as the case may be, to the extent that any such loss, claim, damage or liability of such underwriter, selling Holder or controlling Person results from the fact that such underwriter or selling Holder sold Registrable
Securities to a Person to whom there was not sent or given, at or prior to the written confirmation of such sale, a copy of the final Prospectus as then amended or supplemented, whichever is most recent, if the Company has previously furnished
copies thereof to such underwriter or selling Holder and such final Prospectus, as then amended or supplemented, has corrected any such misstatement or omission. Such indemnity shall remain in full force and effect regardless of any investigation
made by or on behalf of any Holder Indemnitee or any other Holder and shall survive the transfer of such securities. The foregoing indemnity agreement is in addition to any liability that the Company may otherwise have to each Holder Indemnitee.

  

 21 








 (b) Indemnification by Selling Holders. In connection with any Registration Statement in which a
Selling Holder is participating by registering Registrable Securities, such Selling Holder agrees, severally and not jointly with any other Person, to indemnify and hold harmless, to the fullest extent permitted by Law, the Company, the officers and
directors of the Company, and each Person who controls (within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act) the Company, and each underwriter, if any, and each Person who controls (within the meaning
of Section 15 of the Securities Act or Section 20 of the Exchange Act) such underwriter (collectively, “Company Indemnitees”), from and against all Losses, as incurred, arising out of or based on any untrue
statement (or alleged untrue statement) of a material fact contained in any such Registration Statement (or in any preliminary or final Prospectus contained therein, any document incorporated by reference therein or Issuer Free Writing Prospectus
related thereto) or any other offering circular or any amendment of or supplement to any of the foregoing or any other document incident to such registration, or any omission (or alleged omission) to state therein a material fact required to be
stated therein or necessary to make the statements therein (in the case of a final or preliminary Prospectus, in light of the circumstances under which they were made) not misleading, in each case solely to the extent that such untrue statement (or
alleged untrue statement) or omission (or alleged omission) is made in such Registration Statement (or in any preliminary or final Prospectus contained therein, any document incorporated by reference therein or Issuer Free Writing Prospectus related
thereto), offering circular, or any amendment of or supplement to any of the foregoing or other document in reliance upon and in conformity with written information furnished to the Company by such Selling Holder expressly for inclusion in such
document. Such indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of the Company or any of its directors, officers or controlling Persons. The Company may require as a condition to its including
Registrable Securities in any Registration Statement filed hereunder that the holder thereof acknowledge its agreement to be bound by the provisions of this Agreement (including Section 2.5) applicable to it. 
 (c) Conduct of Indemnification Proceedings. If any Person shall be entitled to indemnity hereunder (an “indemnified
party”), such indemnified party shall give prompt notice to the party from which such indemnity is sought (the “indemnifying party”) of any claim or of the commencement of any Action with respect to which such
indemnified party seeks indemnification or contribution pursuant hereto; provided, however, that the delay or failure to so notify the indemnifying party shall not relieve the indemnifying party from any obligation or liability except to the
extent that the indemnifying party has been actually prejudiced by such delay or failure. The indemnifying party shall have the right, exercisable by giving written notice to an indemnified party promptly after the receipt of written notice from
such indemnified party of such claim or Action, to assume, at the indemnifying party’s expense, the defense of any such Action, with counsel reasonably satisfactory to such indemnified party; provided, however, that an indemnified party
shall have the right to employ separate counsel in any such Action and to participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense of such indemnified party unless: (i) the indemnifying party agrees
to pay such fees and expenses; (ii) the indemnifying party fails promptly to assume, or in the event of a conflict of interest cannot assume, the defense of such Action or fails to employ counsel reasonably satisfactory to such indemnified
party, in which case the indemnified party shall also have the right to employ counsel 

  

 22 








 
and to assume the defense of such Action; or (iii) in the indemnified party’s reasonable judgment a conflict of interest between such indemnified
and indemnifying parties may exist in respect of such Action; provided, further, however, that the indemnifying party shall not, in connection with any one such Action or separate but substantially similar or related Actions in the same
jurisdiction, arising out of the same general allegations or circumstances, be liable for the fees and expenses of more than one firm of attorneys (together with appropriate local counsel) at any time for all of the indemnified parties, or for fees
and expenses that are not reasonable. Whether or not such defense is assumed by the indemnifying party, such indemnified party will not be subject to any liability for any settlement made without its consent (but such consent will not be
unreasonably withheld or delayed). No indemnifying party will be subject to any liability for any settlement made without its consent (but such consent will not be unreasonably withheld or delayed). The indemnifying party shall not consent to entry
of any judgment or enter into any settlement that does not include as an unconditional term thereof the giving by all claimants or plaintiffs to such indemnified party of a release, in form and substance reasonably satisfactory to the indemnified
party, from all liability in respect of such claim or litigation. 
 (d) Contribution. (i) If the indemnification provided for in
this Section 2.5 is unavailable to an indemnified party in respect of any Losses (other than in accordance with its terms), then each applicable indemnifying party, in lieu of indemnifying such indemnified party, shall contribute to the amount
paid or payable by such indemnified party as a result of such Losses, in such proportion as is appropriate to reflect the relative fault of the indemnifying party, on the one hand, and such indemnified party, on the other hand, in connection with
the actions, statements or omissions that resulted in such Losses as well as any other relevant equitable considerations. The relative fault of such indemnifying party, on the one hand, and indemnified party, on the other hand, shall be determined
by reference to, among other things, whether any action in question, including any untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact, has been taken by, or relates to information supplied
by, such indemnifying party or indemnified party, and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent any such action, statement or omission. 
 (ii) The parties hereto agree that it would not be just and equitable if contribution pursuant to this Section 2.5(d) were determined by pro rata
allocation or by any other method of allocation that does not take account of the equitable considerations referred to in the immediately preceding paragraph. 
 (iii) No Person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any Person who was not guilty of such fraudulent
misrepresentation. 
 (f) Limitation on Holder Liability. Notwithstanding anything to the contrary contained in this Agreement, an
indemnifying party that is a Holder shall not be required to indemnify or contribute any amount in excess of the amount by which the net proceeds received by such Holder from the sale of the Registrable Securities sold by such Holder in the
applicable offering exceeds the amount of any damages that such indemnifying party has otherwise been required to pay by reason of the applicable untrue or alleged untrue statement or omission or alleged omission. 
  

 23 








 Section 2.6 Rule 144; Rule 144A. The Company covenants that it will file the reports required
to be filed by it under the Securities Act and the Exchange Act and the rules and regulations adopted by the SEC thereunder (or, if the Company is not required to file such reports, it will, upon the request of any Holder, make publicly available
other information so long as necessary to permit sales pursuant to Rule 144 or 144A under the Securities Act), and it will take such further action as any Holder may reasonably request, all to the extent required from time to time to enable such
Holder to sell Registrable Securities without registration under the Securities Act within the limitation of the exemptions provided by (i) Rule 144 or 144A or Regulation S under the Securities Act, as such Rules may be amended from time to
time, or (ii) any similar rule or regulation hereafter adopted by the SEC. Upon the request of any Holder, the Company will deliver to such Holder a written statement as to whether it has complied with such requirements and, if not, the
specifics thereof. 
 Section 2.7 Underwritten Registrations. (a) If any offering of Registrable Securities is an
underwritten offering, the Holders’ Representative shall have the right to select the investment banker or investment bankers and managers to administer the offering, subject to approval by the Company, not to be unreasonably withheld or
delayed. The Company shall have the right to select the investment banker or investment bankers and managers to administer any incidental or piggyback registration. 
 (b) No Person may participate in any underwritten registration hereunder unless such Person (i) agrees to sell the Registrable Securities or Other Securities it desires to have covered by the registration on the
basis provided in any underwriting arrangements in customary form (including pursuant to the terms of any over-allotment or “green shoe” option requested by the managing underwriter, provided that no such Person will be required to
sell more than the number of Registrable Securities that such Person has requested the Company to include in any registration), and (ii) completes and executes all questionnaires, powers of attorney, indemnities, underwriting agreements and
other documents required under the terms of such underwriting arrangements, provided that such Person (other than the Company) shall not be required to make any representations or warranties other than those related to title and ownership of
shares and as to the accuracy and completeness of statements made in a Registration Statement, Prospectus, offering circular, or other document in reliance upon and in conformity with written information furnished to the Company or the managing
underwriter(s) by such Person and, provided further, that such Person’s (other than the Company’s) liability in respect of such representations and warranties shall not exceed such Person’s net proceeds from the offering.

 Section 2.8 Registration Expenses. The Company shall pay all reasonable documented expenses incident to the Company’s
performance of or compliance with its obligations under this Article II, including, without limitation, (i) all registration and filing fees (including fees and expenses (A) with respect to filings required to be made with the SEC, all
applicable securities exchanges and/or the National Association of Securities Dealers, Inc. and (B) of compliance with securities or Blue Sky laws including any fees and disbursements of counsel for the underwriter(s) in connection with Blue
Sky qualifications of the Registrable Securities pursuant to Section 2.3(h)), (ii) printing expenses (including expenses of printing certificates for Registrable Securities in a form eligible for deposit with The Depository Trust Company
and of printing Prospectuses if the printing of Prospectuses is requested by the managing underwriter(s), if any, or by the Holders of a majority of the Registrable Securities included in any Registration Statement), (iii) messenger, 

  

 24 








 
telephone and delivery expenses of the Company, (iv) fees and disbursements of counsel for the Company, (v) expenses of the Company incurred in
connection with any road show, and (vi) fees and disbursements of all independent certified public accountants (including, without limitation, the expenses of any “comfort” letters required by this Agreement) and any other Persons,
including special experts retained by the Company. In addition, the Company shall bear all of its internal expenses (including all salaries and expenses of its officers and employees performing legal or accounting duties), the expense of any annual
audit, the fees and expenses incurred in connection with the listing of the securities to be registered on any securities exchange on which similar securities issued by the Company are then listed and rating agency fees and the fees and expenses of
any Person, including special experts, retained by the Company. In addition, the Company shall pay the reasonable documented fees and disbursements of one firm of counsel for the Holders in connection with each registration under Article II, but the
Company shall not be obligated to pay any underwriting discounts attributable to sales of Registrable Securities by Holders thereof. 
 ARTICLE III 
 MISCELLANEOUS 
 Section 3.1 Conflicting Agreements. Each party represents and warrants that it has not granted and is not a party to any proxy, voting trust or other agreement that is inconsistent with or conflicts with
any provision of this Agreement. 
 Section 3.2 Termination. This Agreement shall terminate at such time as there are no
Registrable Securities, except for the provisions of Sections 2.5, 2.6, 2.8 and this Article III, which shall survive such termination. 
 Section 3.3 Amendment and Waiver. This Agreement may not be amended except by an instrument in writing signed on behalf of each of the Company, Fairholme and, at any time when Fairholme is not the Holder of a majority of the
Registrable Securities, the Holders of a majority of the aggregate number of Registrable Securities then held by all Holders. Any party hereto may waive any right of such party hereunder by an instrument in writing signed by such party and delivered
to the other parties (and, in the case of a waiver of any rights of the Holders at any time when Fairholme is not the Holder of a majority of the Registrable Securities, by an instrument in writing signed by the Holders of a majority of the
aggregate number of Registrable Securities then held by all Holders). The failure of any party to enforce any of the provisions of this Agreement shall in no way be construed as a waiver of such provisions and shall not affect the right of such
party thereafter to enforce each and every provision of this Agreement in accordance with its terms. 
 Section 3.4 Severability.
If any provision of this Agreement shall be declared by any court of competent jurisdiction to be illegal, void or unenforceable, all other provisions of this Agreement shall not be affected and shall remain in full force and effect. 
 Section 3.5 Entire Agreement. This Agreement embodies the complete agreement and understanding among the parties hereto with respect to the
subject matter hereof and supersedes and preempts any prior understandings, agreements or representations by or among the parties, written or oral, that may have related to the subject matter hereof in any way. 
  

 25 








 Section 3.6 Successors and Assigns. Neither this Agreement nor any right or obligation
hereunder is assignable in whole or in part by any party without the prior written consent of the other party hereto; provided that Fairholme may transfer its rights and obligations hereunder (in whole or in part) to any Transferee (and any
Transferee may transfer such rights and obligations to any subsequent Transferee) without the prior written consent of the Company; provided, further, that no such Transferee shall have the right under this Agreement to require a
Demand Registration or participate in a Piggyback Registration if such Transferee (a) is able to immediately sell without restrictions under Rule 144 (or any successor provision) under the Securities Act all of the shares of Common Stock held
by such Transferee, and (b) holds less than one percent (1%) of the then-outstanding shares of Common Stock. Any such assignment shall be effective upon receipt by the Company of (x) written notice from the transferring Holder stating
the name and address of any Transferee and identifying the number of shares of Registrable Securities with respect to which the rights under this Agreement are being transferred and the nature of the rights so transferred and (y) a written
agreement in substantially the form attached as Exhibit A hereto from such Transferee to be bound by the applicable terms of this Agreement. 
 Section 3.7 Counterparts; Execution by Facsimile Signature. This Agreement may be executed in any number of counterparts, each of which shall be an original, but all of which together shall constitute one instrument. This
Agreement may be executed by facsimile signature(s). 
 Section 3.8 Remedies. (a) Each party hereto acknowledges that
monetary damages would not be an adequate remedy in the event that any of the covenants or agreements in this Agreement is not performed in accordance with its terms, and it is therefore agreed that, in addition to and without limiting any other
remedy or right it may have, the non-breaching party will have the right to an injunction, temporary restraining order or other equitable relief in any court of competent jurisdiction enjoining any such breach or threatened breach and enforcing
specifically the terms and provisions hereof. Each party hereto agrees to waive any requirement for the securing or posting of any bond in connection with such remedy. 
 (b) All rights, powers and remedies provided under this Agreement or otherwise available in respect hereof at law or in equity shall be cumulative and not alternative, and the exercise or beginning of the exercise of
any thereof by any party shall not preclude the simultaneous or later exercise of any other such right, power or remedy by such party. 
 Section 3.9 Notices. All notices required or permitted hereunder shall be in writing and shall be deemed effectively given (i) upon personal delivery to the party to be notified, (ii) when sent by confirmed facsimile
if sent during normal business hours of the recipient, if not, then on the next Business Day or (iii) one Business Day after deposit with a nationally recognized overnight courier, specifying next day delivery, with written verification of
receipt. All communications shall be sent to the addresses set forth below or such other address or facsimile number as a party may from time to time specify by notice to the other parties hereto: 
 If to the Company: AmeriCredit Corp., 801 Cherry Street, Suite 3900, Fort Worth, Texas 76102; Attention: Chris A. Choate; Fax: (817) 302-7915; and
with a copy (which shall not constitute notice) to: Hunton & Williams LLP, 1445 Ross Avenue, Suite 3700, Dallas, Texas 75202; Attention: L. Steven Leshin; Fax (214) 880-0011 
  

 26 








 If to Fairholme: Fairholme Funds, Inc., 4400
Biscayne Blvd., 9th Floor, Miami, FL 33137; Attention: President; Fax: (305) 358-8002; and with copies (which shall not constitute notice) to:
Seward & Kissel LLP, 1200 G Street, NW, Washington, DC 20005; Attention: Paul M. Miller; Fax: (202) 737-5184; and Greenberg Traurig, P.A., 401 E. Olas Blvd., Suite 401, Fort Lauderdale, Florida 33301; Attention David C. Peck; Fax
(954) 765-1477 
 Section 3.10 Nature of Holders’ Obligations. The obligations of each Holder under this Agreement are
several and not joint with the obligations of any other Holder, and no Holder shall be responsible in any way for the performance of the obligations of any other Holder under this Agreement. Nothing contained herein, and no action taken by any
Holder pursuant hereto or in connection herewith, shall be deemed to constitute the Holders as a partnership, a joint venture or any other kind of entity, or create a presumption that the Holders are in any way acting in concert or as a group with
respect to such obligations or any of the transactions contemplated by this Agreement. 
 Section 3.11 Governing Law; Consent to
Jurisdiction. (a) This Agreement shall be governed in all respects by the laws of the State of New York, without regard to its conflicts of laws principles. 
 (b) Each of the parties hereto (i) consents to submit itself to the personal jurisdiction of any Federal or state court located in the Borough of Manhattan in the City of New York, New York in the event any
dispute arises out of this Agreement, (ii) agrees that it will not attempt to deny or defeat such personal jurisdiction by motion or other request for leave from any such court and (iii) agrees that it will not bring any Action relating to
this Agreement in any court other than a Federal or state court located in the Borough of Manhattan in the City of New York, New York. 
 (c)
Each of the parties hereto hereby irrevocably and unconditionally waives trial by jury in any legal Action or proceeding in relation to this Agreement and for any counterclaim therein. 
 [signature page follows] 
  

 27 








 IN WITNESS WHEREOF, the parties hereto have executed this Registration Rights Agreement as of the date
first written above. 
  

			
	AMERICREDIT CORP.
		
	By:	 	  

	Name:	 	
	Title:	 	
	
	FAIRHOLME FUNDS, INC.
		
	By:	 	  

	Name:	 	
	Title:	 	









 [EXHIBIT A] 
 AmeriCredit Corp. 
 801 Cherry Street 
 Suite 3900

 Fort Worth, TX 76102 
 Attention: General Counsel 

Ladies and Gentlemen: 
 Reference is made to the
Registration Rights Agreement, dated as of December [    ], 2008 (the “Agreement”). Capitalized terms used and not otherwise defined herein are used herein as defined in the Agreement. The undersigned
(“Transferee”) hereby: (i) acknowledges receipt of a copy of the Agreement; (ii) notifies the Company that, on [Date], Transferee acquired from [insert name of assigning Holder] (pursuant to a private transfer that
was exempt from the registration requirements under the Securities Act) [describe the Registrable Securities that were transferred] (the “Transferred Securities”) and an assignment of such transferor’s rights under the
Agreement with respect and to the Transferred Securities, and the Transferee has assumed from such transferor the liability of the transferor in respect of any and all obligations under the Agreement related to the Transferred Securities; and
(iii) agrees to be bound by all terms of the Agreement with respect to the Transferred Securities applicable to a Holder of such Transferred Securities as if the Transferee was an original signatory to the Agreement. Notices to the Transferee
for purposes of the Agreement may be addressed to: [—], [—], Attn: [—], Fax: [—]. This document shall
be governed by, and construed in accordance with, the laws of the State of New York, applicable to contracts executed in and to be performed entirely within that State. 
  

			
	[Transferee]
		
	[By:]	 	  

	Name:	 	
	[Title:]	 	


 cc: [Transferor]